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ABSTRACT: The microbiome presents great opportunities for understanding and improving the world around us and
elucidating the interactions that compose it. The microbiome also poses tremendous challenges for mapping and manipulating
the entangled networks of interactions among myriad diverse organisms. Here, we describe the opportunities, technical needs,
and potential approaches to address these challenges, based on recent and upcoming advances in measurement and control
at the nanoscale and beyond. These technical needs will provide the basis for advancing the largely descriptive studies of the
microbiome to the theoretical and mechanistic understandings that will underpin the discipline of microbiome engineering.
We anticipate that the new tools and methods developed will also be more broadly useful in environmental monitoring,
medicine, forensics, and other areas.
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MOTIVATION AND GOALS OF THE MICROBIOME
INITIATIVE
The proposed Uniﬁed Microbiome Initiative seeks to develop
and to apply new tools that enable understanding the
microbiomes (and nanobiomes) of humans and other animals,
plants, the earth, the ocean, and the atmosphere.1−3 These
coexisting populations are key components and sustainers of life
as we know it and of our planet. Sometimes these populations are
symbiotic and supportive; at other times, they are dangerous and
destructive. Incredibly, we know little of their compositions,
roles, interactions, and dynamics. Here, we motivate this project
with the major issues and a number of tantalizing sketches of
what we know, what we do not know, and what we would like
to know.
Many diﬀerent approaches will be required to read out the
microbiome and its functions at diﬀerent levels, as well as to
synthesize these data intomodels that can improve our predictive
understanding. In particular, we must determine the correct
scales to read out microbial systems in order to understand
processes from the intracellular to the planetary. This challenge
is formidable because of the sheer diversity and number of
microbes and their functions.
For example, microbial cells have been estimated to outnumber
human cells in each of us by as much as ten to one and to con-
stitute ca. 1 kg in typical adults.4 The microbiome varies greatly
among diﬀerent body sites (for example, our stool and our skin
harbor almost entirely distinct microbial communities),5,6 and
variation is also high within each body site from person to
person.6 Indeed, the diﬀerences between a person’s gut and oral
microbes are comparable to the diﬀerences between microbes in
a soil and an ocean community.7 In addition to the frequently
studied bacteria and archaea, fungi, other microbial eukaryotes,
and viruses play large and underappreciated roles. Most of the
genes in the species that are known are unannotated, and the vast
majority of species have not yet been cultured. Consequently,
we lack even the parts list, let alone systems-level understand-
ing of how the parts interact with one another to support
physiological function. Similar considerations apply to the com-
plex microbial communities that underpin function in the oceans,
freshwater systems, the soil (including the rhizosphere of symbiotic
root microbes that supports plant life), sediments, and perhaps
even the air, where microbial transport is well-documented but
microbial function less so.
Earth Microbiomes. Microbial communities play critical
roles in many distinct processes across our planet. For example,
microbes are essential in all nutrient cycles, including global
carbon8 and nitrogen9 cycles, and provide key ecosystem services
in both marine10 and terrestrial11 environments. Diversity in
some ecosystems is tremendously high, with estimates of the soil
microbial census exceeding 40,000 species per gram.12 In the soil,
in particular, microbes are essential for supporting plant life
and play key roles in mediating nutrient uptake and entry into
the food chain.13,14 Therefore, substantial opportunities exist
for biotechnological applications that alter microbes in order
to improve crop productivity and environmental tolerance,
especially to drought and salt. In addition to their role in plant
growth, soil microbes, notably Streptomyces, provide a major
source of antibiotics, and new antibiotics continue to be isolated
from this source.15 However, despite all this complexity, some
relatively simple drivers, notably pH,16,17 explain much of the
variation. Spatial variation in the soil microbiome is immense,
and even small areas such as the Hoosﬁeld experimental strip
at Rothamstead18 or within a single biome such as the Arctic,19 or
even New York’s Central Park,20 can harbor a large fraction of
the microbial community diversity. However, other factors such
as plant cover tend to have small, although with suﬃcient sample
size, detectable eﬀects.21 There is a substantial need to
understand soil microbes on their own scale, for example,
individual grains of soil, which are often dominated by single
species,22 and understanding how this heterogeneity scales to
overall soil properties remains an important challenge.
Earth is a microbial planet, with micro-organisms dominating
virtually every ecosystem, ranging from soil to oceans, from the
deep subsurface to the atmosphere, including extreme environ-
ments, such as hydrothermal vents. Although microbes are abun-
dant and ubiquitous, we currently lack fundamental under-
standing of many of the key roles played by microbes in Nature,
including cycling of carbon and other nutrients. It has been
estimated that only a small fraction (≪1%) of Earth’s microbes
have ever been isolated and studied in pure culture. This
limitation has resulted in expansive growth of non-culture-
dependent molecular approaches to determine not only the
identities of members of microbial communities in a variety of
habitats but also their functional roles. Recent achievements
include development of a range ofmolecular “omics” approaches.
These include high-throughput sequencing of 16S rRNA genes
as a conserved phylogenetic marker that is the current standard
used to assign identities to largely unknown members
of microbial communities.23 In addition, sequencing of a
microbiome’s total DNA, or metagenomics, has been developed
to determine both the phylogenetic and functional gene
repertoire of microbial communities in environmental samples.24
Metagenomics has already been successfully demonstrated for
environments with relatively low species diversity and, as
sequencing technologies continue to improve the depth of
sequencing, is now becoming suﬃcient to apply metagenomics
to highly complex microbial communities, such as soil.25
Recently, it has been possible to achieve binning of complete
to near-complete composite genomes from a range of environ-
mental samples, including soil, frommetagenome sequence data,
many of which represent previously undescribed species.26,27
One limitation with metagenomics is that the DNA sequence
data do not provide information about what genes are expressed,
and we understand that only a portion of genes are expressed at
any given time, depending on the environmental conditions.
Other omics technologies can compensate for this limitation,
such as sequencing of RNA (metatranscriptomics) or identi-
ﬁcation of proteins (metaproteomics). Finally, characterization
of metabolites (metabolomics) represents the ultimate signature
of processes occurring in any particular environment.
Understanding the direction of some of these inputs is of
critical importance. For example, the permafrost is one of Earth’s
largest carbon reservoirs, estimated at roughly 1600 Pg, about
the same as the amount in the atmosphere and in vegetation.28
Climate change is resulting in higher temperatures in the Arctic
and increased ﬁre frequency that is causing permafrost thaw,
increasing the availability of carbon stored in permafrost to
microbes that can degrade it, resulting in the release of green-
house gases (CO2 and methane).
29,30 Understanding the relative
The diﬀerences between a person’s
gut and oral microbes are comparable
to the diﬀerences between microbes
in a soil and an ocean community.
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sizes of these inputs, and therefore whether lightning (which
leads to ﬁres) is a positive or negative factor in the dynamics of
greenhouse gas emissions, requires a detailed knowledge of the
activities of the microbes in permafrost.31
Ocean Microbiomes and Nanobiomes. Life in the oceans
is supported by a community of extremely small organisms that
can be called a “nanobiome.” These nanoplankton particles,
many of which measure less than 0.001× the volume of a white
blood cell, harvest solar and chemical energy and channel
essential elements into the food chain. A deep network of larger
life forms (humans included) depends on these tiny microbes for
its energy and chemical building blocks.
The importance of the oceanic nanobiome has only recently
begun to be fully appreciated. Two dominant forms,
Synechococcus and Prochlorococcus, were not discovered until
the 1980s and 1990s.32−34 Prochloroccus has now been dem-
onstrated to be so abundant that it may account for as much as
10% of the world’s living organic carbon. The organism divides
on a diel cycle while maintaining constant numbers, suggesting
that about 5% of the world’s biomass ﬂows through this species
on a daily basis.35−37 Metagenomic studies show that many other
less abundant life forms must exist but elude direct observation
because they can neither be isolated nor grown in culture.
The small sizes of these organisms (and their genomes)
indicate that they are highly specialized and optimized.
Metagenome data indicate a large metabolic heterogeneity
within the nanobiome. Rather than combining all life functions
into a single organism, the nanobiome works as a network of
specialists that can only exist as a community, therein explaining
their resistance to being cultured. The detailed composition of
the network is the result of interactions between the organisms
themselves and the local physical and chemical environment.
There is thus far little insight into how these networks are formed
and how they maintain steady-state conditions in the turbulent
natural ocean environment.
The serendipitous discovery of Prochlorococcus happened by
applying ﬂow cytometry (developed as a medical technique
for counting blood cells) to seawater.34 With these medical
instruments, the faint signals from nanoplankton can only be
seen with great diﬃculty against noisy backgrounds. Currently,
a small team is adapting ﬂow cytometric technology to improve
the capabilities for analyzing individual nanoplankton particles.
The latest generation of ﬂow cytometers enables researchers to
count and to make quantitative observations of most of the small
life forms (including some viruses) that comprise the nano-
biome. To our knowledge, there are only two well-equipped
mobile ﬂow cytometry laboratories that are regularly taken to sea
for real-time observations of the nanobiome. The laboratories
include equipment for (meta)genome analysis and equipment to
correlate the observations with the local physical parameters and
(nutrient) chemistry in the ocean. Ultimately, integration of
these measurements will be essential for understanding the
complexity of the oceanic microbiome.
The ocean is tremendously undersampled. Ship time is costly
and limited. Ultimately, inexpensive, automated, mobile biome
observatories will require methods that integrate microbiome
and nanobiome measurements, with (meta-) genomics analyses,
with local geophysical and geochemical parameters.38−42 To
appreciate how the individual components of the ocean biome
are related and work together, a more complete picture must be
established.
The marine environment consists of stratiﬁed zones, each
with a unique, characteristic biome.43 The sunlit waters near the
surface are mixed by wind action. Deeper waters may be mixed
only occasionally by passing storms. The dark deepest layers are
stabilized by temperature/salinity density gradients. Organic
material from the photosynthetically active surface descends
into the deep zone, where it decomposes into nutrients that are
mixed with compounds that are released by volcanic and seismic
action. These nutrients diﬀuse upward to replenish the depleted
surface waters. The biome is stratiﬁed accordingly, sometimes
with sudden transitions on small scales. Photo-autotrophs dom-
inate near the surface. Chemo-heterotrophs populate the deep.
The makeup of the microbial assemblages is dictated by the local
nutrient and oxygen concentrations. The spatiotemporal inter-
play of these systems is highly relevant to such issues as the
carbon budget of the planet but remains little understood.
Atmospheric Microbiome. Microbes make up a sizable
fraction of atmospheric aerosols, as they are suspended from soil,
water, and plant surfaces.44−52 The number of studies detailing
microbial communities in terrestrial and ocean sources vastly
exceeds those describing airborne microbes.53 Understanding
the sources contributing to the atmospheric nanobiome is an area
of major recent growth, with recent studies demonstrating that
atmospheric microbes can be ubiquitous, vary spatially, and
remain suspended for days to weeks.54 Average measured
atmospheric concentrations of microbes have been reported to
be 102−104 cells m−3 over land with lower levels over the ocean
(∼102 cells m−3).55−57 However, large uncertainties exist in the
atmospheric concentrations due to the limited number of
measurements, low abundance, contamination issues, and the
fact that most airborne bacteria cannot be cultured.44
The atmosphere serves as an eﬀective conduit, transporting
both free and particle-associated microbial life attached to dust
and free microbes around the globe on time scales on the order of
2 weeks.58 The global dissemination of microbes has important
ramiﬁcations for agriculture, infectious disease, human health,
clouds, precipitation, and our water supply. The extreme envi-
ronmental conditions of the upper atmosphere in essence select
which microbes will become dispersed as only certain microbes
can remain viable under harsh irradiation and temperature con-
ditions. However, viable microbes attached to soil dust can remain
viable, even after transport across thousands of miles.57,59,60
At high altitudes, microbes can serve as cloud seeds and can
profoundly impact climate and precipitation processes.61−64
Viable microbes occur in cloud droplets and play signiﬁcant roles
in controlling aqueous-phase chemical processes.65−69 Microbes
can nucleate ice in clouds at warmer temperatures than any other
particle type; thus, the atmospheric microbiome can enhance
precipitation processes.62,70 While most studies have focused on
the ice-nucleating ability of mineral dust,71,72 microbes such as
Pseudomonas syringae are far more eﬀective agents in this climate-
driving activity.73−75 Measurements of airborne ice crystals
have shown that dust and biological particles from as far away as
Africa can form ice in mixed-phase clouds and determine the
amount of snowfall over California’s Sierra Nevada mountains in
California.62
Rather than combining all life functions
into a single organism, the nanobiome
works as a network of specialists that
can only exist as a community
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Many studies have focused primarily on terrestrial sources of
atmospheric microbes, and thus, far less is known about oceanic
sources.76 Estimates of global microbial emissions assume negli-
gible oceanic contributions and range from 40 to 1800 Gg dry
weight year−1.77 However, oceans cover 71% of the Earth’s sur-
face and contain marine bacteria at concentrations of 106−
108 per m−3. When waves break and bubbles burst at the surface
of the ocean, microbes become highly enriched in the ejected sea
spray droplets.78 Thus, sea spray aerosol represents a signiﬁcant
but highly undetermined source comprising a complex mixture
of microbial species. Given the large role in cloud formation,
studies over many decades have investigated the ocean as a
potential source of ice nuclei.79,80 The paucity of knowledge
regarding oceanic contributions to the atmosphere can be
attributed to the diﬃculty associated with isolating solely oceanic
sources given the complexity of the atmosphere and terrestrial
impacts even in remote marine environments. Many studies have
been conducted over the oceans, showing broad diversity, even at
high altitudes (8−15 km).81−83 It remains unclear whether sea
spray production processes selectively introduce only certain
types of microbes into the atmosphere. A recent study impinged
a water jet on the surface of Arctic seawater and showed
signiﬁcant diﬀerences in the microbes that became aerosolized,
suggesting selectivity can indeed occur.84 The transfer of dif-
ferent species from seawater to the atmosphere strongly depends
on the bubble size distribution and, hence, the physical
mechanisms of bubble production.85 Thus, in order to replicate
sea spray aerosol composition more accurately, breaking waves
were used to produce sea spray aerosol using realistic bubble sizes
and hence physical production mechanisms.86 Studies are now
underway using more realistic ocean-in-the-lab breaking-wave
approaches to isolate and to develop a library of ocean-derived
microbes that will ultimately be used to determine the relative
contributions of the ocean to the atmospheric nanobiome.
Future studies will examine how phytoplankton blooms, as well
as the chemistry and morphological properties of the microbes,
impact their transfer into the aerosol phase, as well as the ability
of the ejected microbes to remain viable under typical atmo-
spheric conditions.87
Microbes of Humans and Other Animals. Microbiomes
play important roles in the health of many animals, including
humans, and disruption of these microbe−host interactions
by exposure to certain diets or chemicals can lead to dysbiosis in
the host (see Box 1). Host-associated microbial communities
range from those involving a single bacterial species, such as
the symbionts of certain insects, squids, and other invertebrates,
up to the hundreds to thousands of species present in the
mammalian gut. Diﬀerent mammals contain microbiomes
that range from relatively simple, for carnivores, to the complex,
notably in herbivores that ferment cellulose in their hindguts
(omnivores and foregut fermenters being intermediate in
complexity). In addition to digestion, mammalian gutmicrobiomes
perform many other functions, including producing essential
amino acids and vitamins, regulating the immune system, providing
resistance to disease (including diseases not localized in the gut, e.g.,
liver disease and asthma), and even modifying appetite, circadian
rhythm, and behavior.
Links between the human gut microbiome and disease have
been of intense interest, with strong associations and high-quality
predictive models being reported between the gut micro-
biome and conditions ranging from obesity to type-2 diabetes
to cirrhosis to rheumatoid arthritis. Mouse models provide the
opportunity to unravel possible mechanisms for some of these
associations and, additionally, have linked the gut microbiome
to models of anxiety, depression, and even autism.103 The latter
case is especially interesting because maternal immune activation
via a double-stranded RNA virus induces autism-like behaviors
including repetitive behavior, cognitive and social deﬁcits, as well
as gut barrier dysfunction often seen in humans with autism.
These phenotypes can be reproduced in part using 4-ethyl-
phenylsulfate (4EPS), which is produced by an aberrant
microbial community in the autism model, and can be rescued
with a Bacteroides fragilis probiotic strain.
Of particular interest is fecal transplantation, a procedure in
which stool is transferred from a healthy donor to an unhealthy
recipient (perhaps the same person, in the case of autologous
stool transplant). This procedure has been 90−95% eﬀective for
treating Clostridium diﬃcile-associated disease versus only 20−
30% eﬃcacy for antibiotics. Understanding which other diseases
associated with dysbiosis of the microbiome could be corrected
remains a major goal of microbiome research. The current
regulatory framework in the United States, regulating stool as a
drug and requiring an investigational new drug (IND) appli-
cation for any application other than C. diﬃcile, however, is a
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substantial barrier to research. Understanding more generally
how various therapies including antibiotics, probiotics, prebiotics
(essentially, fertilizer for the microbiome), phage therapy, etc.
can reshape the microbiome remains a major technological and
theoretical challenge.
As noted above, other mammals also have species-speciﬁc
microbiomes, andmany veterinary applications exist, from curing
diseases such as inﬂammatory bowel disease and irritable bowel
syndrome, and perhaps obesity, that plague domestic pets (obese
owners tend to have obese pets, and sharing of microbes among
family members including nonhuman family members has been
demonstrated).104 Additionally, manipulation of the microbiome
to promote growth, to feed conversion eﬃciency, to manipulate
body composition, and to improve disease resistance in livestock
is a major area of interest. One could also imagine manipulating
the microbiome for performance enhancement, for example, in
horses and greyhounds, although little information on this topic
is available in the literature to date.
Microbiomes outside the gut also play important roles,
although most investigations have focused on either deﬁning
a healthy baseline community (without speciﬁc regard to
function)105 or on looking for diﬀerences associated with speciﬁc
diseases.106 The oral microbiome has received intense scrutiny in
the context of tooth decay and gum disease,107−109 the vaginal
community is associated with bacterial vaginosis,110,111 as well
as susceptibility or resistance to yeast and viral infections.112
The skin community has been linked to acne,113 psoriasis,114 and
atopic dermatitis115 and may play a role in resisting infections,116
stimulating the immune system,117 and potentially even risk of
melanoma.118
The dynamics of the human microbiome remain relatively
poorly understood, as few high-resolution time-series studies
have been conducted.119 The microbiome is initially seeded with
diﬀerent microbes depending on delivery mode, either vaginal
microbes from passing through the birth canal or skin microbes
acquired from the environment or from people touching the
baby after C-section.120 After that, the approach to the adult state
takes about 3 years in the gut,121,122 but the time scale is
unknown in other body habitats. Development often appears
chaotic early on, although whether this is an intrinsic property of
the system or due to extrinsic forcing is not known at present.
Similarly, whether early life events have relatively little impact
because of the profound changes during this period or have
a large impact in shaping the microbiome for life-long health is
also unknown. However, exposure to allergens such as pets
seems to have highly time-dependent eﬀects (prenatal to ﬁrst
3 years of life exposure reduces asthma and pet allergies later;
exposure as a teenager increases risk123), and early life antibiotics
increase the likelihood of obesity in a range of species.124
Understanding how the microbiome can change and how we can
develop predictive models that allow responses to everything
from artiﬁcial sweeteners to diets to drugs aﬀect the individual is a
major goal of the ﬁeld. Antibiotic resistance is a major threat;
diagnostics and surveillance at the clinical and public health levels
are required.125,126 The tools developed here will be applicable to
these eﬀorts, and as noted above, the origins of resistance are also
of intense interest in understanding microbiomes.
Microbial Ecology. Microbial communities are a pervasive
and central part of every ecosystem on the planet, including our
own bodies, as discussed above. Since their discovery, developing
methods to detect and to characterize the bacteria, archaea,
viruses, and protists that constitute the microbial world has
driven technological research for microbiologists and microbial
ecologists.127 What started as a need to “see” the microbial world
led to the development of microscopes and has now escalated
into an explosion of technologies aimed at classifying the species
that exist, their cellular metabolism, their impact on the chemical
world around them, and the biosphere at large.128,129 While
many techniques exist to understand the microbial world, these
can be divided into two themes: culture-dependent and culture-
independent, the diﬀerence being whether the microbe is grown
in vitro or characterized in its environmental state. The use of
DNA as a marker of microbial diversity or function in an environ-
ment was realized in the 1970s.130 This led to the development of
technologies aimed at characterizing the microbial world using
DNA or RNA. Culture-dependent analyses leveraged polymer-
ase chain reaction (PCR) and genomic sequencing to determine
the phylogeny and evolutionary history of the bacteria growing
on plates, while PCR and metagenomics were being applied to
characterize the microbes from DNA extracted from their native
environment.
Currently, microbial community characterization is predom-
inantly performed using speciﬁc growth media and sequencing
for genomics, metagenomics, metatranscriptomics, as well as an
array of molecular detection technologies.131 Using 1 ng of DNA
extracted from a cotton swab sample, we can now sequence the
metagenome of the bacteria found there and assemble their
genomes in a routine manner.132,133 This detection threshold
and data resolution are unparalleled in the history of our ﬁeld.
However, the methods used to acquire and to process samples
and to sequence this genetic material have considerable limita-
tions. Chief among these is the ability to sample and to char-
acterize microbial communities remotely in a cost-eﬀective manner,
at spatial and temporal densities of observations that enable
researchers to assess the natural gradients of diversity, the
longitudinal ﬂuctuations in community structure, and the routine
detection of particular organisms in a quantiﬁable manner.
Microbial ecology research has generated many hypotheses
that require dense spatial and temporal sampling to test and to
reﬁne. For example, determining the connectivity of microbial
communities in river systems requires genotype-level resolu-
tion observation of bacteria at regular temporal and spatial
frequencies. Only with a dense grid of simultaneous observations
are we able to capture the dynamic dispersal and interaction of
assemblages of bacterial taxa. In the absence of technology that
enables this set of measurements, studies use two approaches:
deep observation of few samples or shallow observation of many
samples. For example, ultradeep sequencing of taxonomic or
functional marker genes provides insights into the composition
of speciﬁc microbial ecosystems, but without analyzing larger
numbers of samples, limitations arise: the statistical signiﬁcance
of observed patterns cannot be determined, the patterns of co-
occurrence between genes and taxa are diﬃcult to assess, and the
dominant biotic or abiotic factors structuring communities
across time and space remain undetermined. Thus, for microbial
ecology, many samples from related or contrasting communities
must be studied in parallel.127,128
Currently, collecting these samples is nearly always a manual
activity, requiring many hours of human eﬀort. Additionally,
processing of these samples occurs in a laboratory, often long
after the sampling has occurred, so that all data generated are
retrospective. While the data streams generated from these
studies are rich and vast, to elucidate ecological processes at
the scale of an ecosystem relevant to landscape-scale processes or
speciﬁc applied utility requires continuous, remote, and spatio-
temporally dense measurements. An example of this challenge is
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monitoring river systems. The state of the art requires manual
sampling, DNA preparation, and analysis, which limits the depth
and breadth of observations and hence the ecological signiﬁcance
of the ﬁndings. A recent study focusing on the water catch-
ment scale biogeography of microbial distribution examined 23
samples across a river basin (Figure 1A) from a single time point
and used the data to describe the ecological dynamics across
this system.134 This study provided an observational density of
one sample per 432 km2 of the river basin. To get two orders
of magnitude improvement in the observational density of this
river basin would require analysis of ∼2000 water sampling loca-
tions every 6 h for a month. This requirement would enable an
observational density of 5 km2 per sample (Figure 1B) but would
also add a temporal element with 120 time points. This change
multiplies the observational density to create 242,000 obser-
vations within a single month. With this data set, we would be
able to determine the diurnal ﬂuxes in microbial community
density and composition, explore pulses in river community
structure in response to river ﬂow, allochthonous input
(including waste discharge events), and weather patterns, and
understand the true stability and biogeography of the river
system. This study would provide us with the opportunity to
use the microbial assemblages as an early warning system of
shifts in ecological function and stability, to create a dynamic
distribution model of river activity and its impact on biogeo-
chemistry and response to pollution, and to devise novel
ecological principles about the connectivity of microbial assem-
blages in these ﬂuid systems.
A more applied example would be to develop the ability to
monitor combined sewage overﬂow outlets or human stool or
oral samples to determine the temporal ﬂux in microbial
community structure. Developing sensor platforms that could be
used to monitor microbial communities routinely would be
useful for detecting pathogen release into river systems or shifts
in microbial community in stool or saliva that could be used
as biomarkers for disease and health. One space in which
monitoring could have enormous impact on human activities and
health would be in urban built environments. The melting pot of
humans, animals, plants, and water in cities creates a complex
microbial meta-ecosystem that critically inﬂuences human
health. In the urban environment, diverse microbes can migrate
rapidly by water or air, colonize new niches, transfer between
animal and human hosts, develop new functional capabilities, and
transform urban metabolites. Environmental infectious disease
transmission is a central problem for high-density urban environ-
ments. One hundred years ago, concerns about disease triggered
the International Joint Commission study of trans-boundary
microbial contamination in the Great Lakes, one of the largest
urban eﬀorts ever conceived. Today, key questions remain
unanswered. How do urban sources and ecosystem dynamics
aﬀect microbial pathogen distributions? Is microbial water
quality improving or deteriorating? What actions are needed to
make soil, air, and water quality sustainable? Under increasing
pressure from growing urban populations, renewed interest in
addressing these questions is creating an impetus to develop
novel technology to create data sets capable of tracking and
monitoring the microbial health of our cities.
Microbial ecology is an important ﬁeld for many aspects of
human activity, from ecosystem restoration to food security,
from urban sustainability to water resource management. To
understand the systems that are vital for our health and well-
being, it is essential that we develop mechanisms to observe the
microbial world at suﬃciently detailed and broad spatial and
temporal resolutions. At a fundamental level, we need to
parametrize the dynamics of microbial species, so that they can
be modeled and predicted. Existing tools for characterizing the
microbiome require either automated or manual collection of
samples and use expensive, cumbersome apparati that require
extensive personnel and time. In addition, devices need to be
accessed regularly, cannot be remotely deployed, and cannot
send back data without extensive robotization, which can be
prohibitively expensive (i.e., remote-operated submarines133).
When they are collected, most samples need to be processed
for DNA extraction, PCR, and sequencing in the laboratory,
which, while generating a popular data product, is expensive and
time-consuming. Although technology does exist for remote,
inexpensive characterization of microbial communities, the
samples still need to be manually collected and manipulated.135
Addressing these challenges will require a cross-disciplinary
program of technology development for automated sampling
devices to enable the repeated characterization and remote data
transfer of the microbiome. These technologies must enable
integrated high spatiotemporal characterization of microbiomes
with similar eﬀorts to characterize the physicochemical and phys-
iological properties of these environments. The ability to capture,
Figure 1. (A) Map of regional study design for a state-of-the-art
exploration of microbial diversity across a river catchment.
Reproduced with permission from ref 134. Copyright 2015 Nature
Publishing Group. (B) Example of coverage provided by dense grid
of sensors for automated water-borne microbiome sampling.
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to analyze, and to model these data also represent signiﬁcant
challenges.136
Bioﬁlm Formation. In most biological, biomedical, and
industrial circumstances, multiple microbial taxa typically form
communities and can exist in bioﬁlms. These microbial
communities are highly structured and exhibit subtle patterns
of spatial organization, as exempliﬁed by microbial mats and soil
communities in the environment and by communities that live
within animal hosts, such as those in dental plaque, the
gastrointestinal tract, and the lungs of cystic ﬁbrosis patients.
The distribution and behavior of species in these communities
inﬂuence and are inﬂuenced by the role they play in a speciﬁc
ecology or ecological trajectory. Important factors include
patterns of cooperation and competition, environmental
conditions, as well as the microbiology of individual species. It
is in this last context, the microbiology of bioﬁlms of individual
species, where we have the most knowledge at present. This
corpus of work provides us with a repertoire of concepts. There
are ﬁve steps in the “standard model” of bioﬁlm development:
(1) free swimming planktonic bacteria attach reversibly to a solid
surface and migrate on the surface; (2) bacterial cells adhere
“irreversibly” to a surface and secrete extracellular polysacchar-
ides; (3) microcolonies of 50−100 bacteria are formed, in a step
that is sometimes described as the ﬁrst social step in the develop-
ment of a bioﬁlm community; (4) a mature, spatially structured
bioﬁlm develops via a process of extracellular polymeric
substances (EPS) production, signaling, motility, cell division;
and (5) free swimming cells are released from the community
and in turn repeat the process. Recent work on bioﬁlm develop-
ment invokes, reﬁnes, and sometimes modiﬁes this paradigm.
Illustrative examples without any attempt at completeness
follow. Cells that land on a surface undergo complex processes
of surface sensing,137 which is just beginning to be understood.
The transition from free swimming to bioﬁlm physiology is often
dependent on cyclic di-GMP, a bacterial secondary messenger,
which has emerged to be kind of master regulator that impacts
bioﬁlm formation, EPS production, bacterial motility, virulence,
and other processes.138 Extracellular communication becomes
more important; an important example with strong phenotypic
impact is quorum sensing,139−141 which remains an active area of
study. Secreted extracellular polysaccharides are a deﬁning
characteristic of bioﬁlms, but they are not simply secreted passive
adhesins and can have important social functions in controlling
surface motility in the early assembly of microcolonies.142
Ultimately, bioﬁlms produce a complex matrix of EPS, which
include proteins, lipids, lipopolysaccharides, nucleic acids, as
well as extracellular polysaccharides, that serves as scaﬀolds
for the community. An outstanding challenge for our ﬁeld is to
generalize our existing ideas for single-species communities and/
or to come up with the analogues of these guiding principles for
multispecies communities.
The strategies we use for studying communities with two to
three species will be diﬀerent from those with 100 species, but
both will be crucial for the development of our understanding.
Model communities with simpliﬁed interactions will be helpful in
this regard; Silver and co-workers have proposed and developed
the tools to create a simpliﬁed gut microbiome that lives and
interacts within a mouse model.143−145 Special considerations
are being built into such systems to enable manipulation of the
microbiome and to contain it within the experimental model.
Solving this complex problem of understanding microbial
communities is like learning a new language without a dictionary
or knowledge of grammar: the fastest approach may be to learn
a language like a childthrough imitation and trend identiﬁ-
cation in complex examples of linguistic usage. However, to
achieve the most powerful and nuanced linguistic expression, a
framework of rules needs to be established. We will ultimately
need to study realistic communities with the full diversity of
species. Model systems with a small number of species can be
used to identify predictive rules that help make sense of the
trends. In this spirit, there are a number of interesting examples of
studies that engage multispecies bioﬁlm communities.
Cooperation and Competition in Single-Species
Bioﬁlms. Even in single-species bioﬁlms, good examples of
cooperative and competitive interactions have been reported. In
P. aeruginosa, stratiﬁed patterns of protein synthesis and growth
have been demonstrated.146 Using green ﬂuorescent protein
(GFP) reporter gene constructs, it was found that active protein
synthesis was conﬁned to a narrow band in the part of the bio-
ﬁlm adjacent to the oxygen source. The zone of active GFP
expression was approximately 60 μmwide in colony bioﬁlms and
30 μm wide in ﬂow cell bioﬁlms. Mature P. aeruginosa bioﬁlms
contain active, growing cells. However, these bioﬁlms also
comprise large numbers of inactive cells. A recent example of the
subtle interplay of cooperation and competition in these bifur-
cated populations can be seen in Bacillus subtilis. The complex
relationship between peripheral cells and interior cells in a two-
dimensional (2D) B. subtilis community leads to oscillatory
growth.147 A kind of mutualism emerges. Peripheral cells protect
the interior fromexternal cytotoxic agents but also starve the interior
of nutrients. A novel phenotype with metabolic codependence
emerges, one in which the growth halts periodically, which can, in
principle, beneﬁt interior cells and increase nutrient availability.
Cooperation and Competition in Two-Species Bio-
ﬁlms.The recurring theme of spatial structuring, already evident
from the above, can be seen in two-species consortia. One
example is cocultures of Acinetobacter sp. C6 and Pseudomonas
putida, two soil-inhabiting bacteria that are members of a
microbial consortium isolated from a creosote-polluted aquifer.
In the presence of aromatic carbon sources, the two species
enter into a symbiotic relationship, where Acinetobacter plays the
role of host and P. putida plays the role of a commensal.148
Acinetobacter metabolizes benzyl alcohol to benzoate. Since
P. putida metabolizes benzoate produced by Acinetobacter, it
mutates to have enhanced ability to attach to Acinetobacter and
forms a “mantle” over Acinetobacter microcolonies. As a result,
the two-species consortium has increased stability and pro-
ductivity relative to their isolated counterparts. Implicit in this
relationship is the adaptation of motility to facilitate this organi-
zation. It will be interesting to see how the rules for monospecies
microcolony formation are altered in this two-species consortium.
Recent work has suggested that small multicellular clusters rather
than single cells can move on the surface and coalesce into
microcolonies. Another demonstration of the role played by
motility in generating spatially structured communities can be
found in rRNA ﬂuorescent in situ hybridization (FISH) confocal
microscopy observations on cocultures of Burkholderia sp.
LB400 and Pseudomonas sp. B13(FR1).149 When the consortium
was fed citrate as the carbon source, which can be metabolized by
both Pseudomonas and Burkholderia, the two species formed
separate microcolonies. However, when the carbon source was
changed from citrate to chlorobiphenyl, Pseudomonas used their
surface motility to form mixed microcolonies with Burkholderia,
as the former can metabolize chlorobenzoate produced by the
latter when grown on chlorobiphenyl.
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Of course, not all two-species consortia enter into symbiotic
relations. Some relationships end in competition. The airways of
cystic ﬁbrosis patients are colonized with bacterial communities
that evolve over time. Staphylococcus aureus is the most prevalent
species in early childhood, but Pseudomonas aeruginosa domi-
nates the ecology in early adulthood. In a recent coculture
experiment on P. aeruginosa and S. aureus on monolayers of
human bronchial epithelial cells with the ΔF508 cystic ﬁbrosis
transmembrane conductance regulator (CFTR) mutation,150 it
was shown that P. aeruginosa drives the S. aureus expression
proﬁle from that of aerobic respiration to fermentation. Although
the reasons for this ecological shift are complex, two key factors
have been identiﬁed: the production of Fe-chelating side-
rophores by P. aeruginosa and its preferential consumption of
S. aureus-produced lactate over other carbon sources. It has
been established that S. aureus induces the production of
quinolone quorum sensors and subsequent bioﬁlm formation in
P. aeruginosa.151 Although S. aureus and P. aeruginosa can initially
coexist, P. aeruginosa eventually reduces S. aureus viability in
extended cocultures.
Cooperation and Competition in Three-Species Bio-
ﬁlms. Generalizing from a two-species consortium to a three-
species consortium greatly expands the range of possibilities in
mutualistic relationships. A recent example is a ternary model
bioﬁlm community of Pseudomonas aeruginosa, Pseudomonas
protegens, and Klebsiella pneumonia,152 where the results are quite
suggestive. The biomass of K. pneumonia KP-1 within the mixed
consortium was signiﬁcantly greater than the biomass of single-
species KP-1 bioﬁlms, despite having to contend, in principle,
with the increased competition with P. aeruginosa and P. protegens.
Moreover, the increased community-level resistance to amino-
glycoside antibiotics is striking: P. protegens produces the infamous
aminoglycoside-modifying enzyme N-acetyltransferase, which
causes aminoglycoside antibiotics to bind ineﬃciently to bacterial
ribosomes, so that it can no longer inhibit bacterial protein
synthesis. Although P. protegens comprises only∼15% of the total
biomass, it is able to confer protection to both P. aeruginosa and
K. pneumoniae, so that only 10% of the mixed bioﬁlm is removed
by the aminoglycoside antibiotic tobramycin. These model sys-
tems represent a large and underexplored frontier of microbiology
and promise to attract and to reward attention.
TECHNOLOGY STATUS AND NEEDS
Three areas of technology development will underline the
breakthroughs needed to advance the biological questions
described above: (1) sequencing and identifying microbial macro-
molecules and metabolites, (2) increased speed and standardi-
zation of bioinformatics tools, and (3) development and application
of high-resolution imaging approaches to couple biochemical
analyses with micron-scale microbe−microbe and microbe−tissue
interactions. Although DNA sequencing technologies are currently
high throughput and inexpensive, the same cannot be said for other
omics technologies, such as metatranscriptomics, metaproteomics,
andmetabolomics, which are still primarily run one sample at a time
and require special equipment and expertise. To elucidate the
functional roles of members of complex microbial communities,
new and better technologies are required for higher dynamic range,
speed of analysis, and throughput. In addition, more complete and
validated databases are needed for protein and metabolite identi-
ﬁcation. Advances in imaging technologies are needed to enable
spatial localization of microbial cells and individual proteins in
environmental matrices. Imaging tools for multiscale imaging,
beyond conventional light/electron correlative microscopy tools,
are needed, such that molecular, cellular, bioﬁlm, and larger scales
can be examined and inter-related.
High-Speed, High-Throughput Genomic Sequencing
and Annotation.Genome sequencing, although insuﬃcient for
determining function, is still critical as a ﬁrst step to under-
standing the function of novel organisms and ecosystems.
Sequencing technologies for DNA have rapidly improved,
achieving cost savings of over a million-fold in the past
15 years. However, there remain many barriers to overcome.
First, the technologies that are currently highest throughput, such
as the Illumina sequencing by synthesis platform, produce only
short fragments of DNA.153 Although these short fragments are
extremely useful when mapped against a reference database, such
as is available for the human genome and for model microbes,
de novo assembly and annotation remain a major challenge, and
many technical parameters such as insert size, read length, and
depth of sequencing are not standardized across projects (nor are
their eﬀects on the ﬁnal assembled genome known, in general).
Second, long-read technologies, such as zero-mode waveguide
sequencing (e.g., Paciﬁc Biosciences) and nanopore-based
sequencing (e.g., Oxford Nanopore), are both low-throughput
and error-prone and cannot yet operate on very small amounts of
input material.154,155 Current methods for amplifying genomic
DNA tend to introduce biases that greatly decrease the eﬃciency
of sequencing because the parts of the genome that are ampliﬁed
themost are read over and over again. However, these longer reads
have proven useful for genome assembly, which is necessary for
understanding higher-order structure, gene regulation, and reveal-
ing which components of the genomemost likely work together in
operons. A recent long-read method has extremely low error
rates156 (and is being commercialized157).
Single-cell sequencing (discussed below) remains a challenge
and, despite many recent improvements, typically recovers only
70−90% of a genome. Understanding how to integrate partial
signals from many cells, or to coax a cell through a few cycles of
division before sequencing to reduce stochastic losses such as
DNA attached to the cell wall and therefore lost to sequencing,
remains largely unexplored. The dream system would be to
separate single cells from complex matrix such as stool, soil, or
bioﬁlm, disrupt them in situ, and to separate each into a single
library for highly multiplexed sequencing on a cheap long-read
platform, ideally simultaneously reading out the DNA, the RNA,
and any modiﬁed nucleotides at either level (for example,
methylated nucleotides in the DNA are important for under-
standing gene regulation, and many types of modiﬁed bases in
the RNA, including inosine, can alter the meaning of the
transcript relative to what is encoded in the genome), all at low
cost. However, the technology for performing these tasks has not
been developed, although various microﬂuidic protocols show
enormous promise in library preparation. Cellular isolation and
disruption at high throughput remains a considerable challenge,
as the impedance mismatch between a physical specimen and
vast numbers of single-cell genomes is presently large.
Obtaining the DNA sequence is not suﬃcient: although most
bacterial, archaeal, and viral DNA consist of protein-coding
genes, the same is not true for microbial eukaryotes, and even
in compact genomes, the regulatory elements (including siRNAs,
miRNAs, CRISPR repeats, etc.) are important to understand
both from functional and from evolutionary perspectives. Improved
methods for understanding the functions of protein-coding genes,
including structural genomics, computational structure prediction of
sequences of unknown function that might be members of highly
diverged protein families, and high-throughput expression followed
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by assays of biochemical function (that could be improved by
mass spectrometry and other high-throughput chemical proﬁling
techniques to identify novel biotransformations), are urgently
needed. Expression data under diﬀerent conditions, perhaps
involving other organisms as well as pure cultures, may be
necessary for understanding the functions of novel regulatory
elements, although such studies are extremely time-consuming
with existing techniques and impractical to apply to the vast
majority of organisms that cannot yet be grown in culture. Addi-
tionally, compiling large databases of single-cell genomes and
community metagenomes from environmental samples would
allow us to understand the functions of unknown proteins
and regulatory elements by identifying other genes, species, or
environmental conditions with which they are associated (again,
expression data at the RNA, protein, and/or metabolite level
would be especially helpful here). An important side eﬀect of
these eﬀorts would be improved understanding of how microbial
communities function, which would assist in modeling eﬀorts.
Finally, many enzyme functions are known but not relatable to
a single protein sequence, and many protein sequences have had
their functions determined, but the annotations are in individual
publications and not yet aggregated into machine-readable data-
bases. Consequently, a focused eﬀort to identify these missing
enzymes and to apply sophisticated natural language processing
(NLP) techniques such as IBM’s Watson technology158 to the
biochemical literature could be especially useful in leveraging
existing eﬀorts in knowledge generation. One could also imagine
nanosensors for enzyme function that might be able to read out
a suite of possible enzyme activities better than currently avail-
able biochemical assays, each of which typically covers only a
restricted range of chemistries.
Nanoscience and Nanotechnology Opportunities. The
great advantage of nanoscience and nanotechnology in studying
microbiomes is that the nanoscale is the scale of function in
biology. It is this convergence of scales at which we can “see” and
at which we can fabricate that heralds the contributions that can
be made by developing new nanoscale analysis tools.159−168
Microbiomes operate from the nanoscale up to much larger
scales, even kilometers, so crossing these scales will pose signif-
icant challenges to the ﬁeld, in terms of measurement,
stimulation/response, informatics, and ultimately understanding.
Some progress has been made in creating model sys-
tems143−145,169−173 that can be used to develop tools and
methods. In these cases, the tools can be brought to bear onmore
complex and real systems. Just as nanoscience began with the
ability to image atoms and progressed to the ability to manipulate
structures both directly and through guided interactions,162,163,174−176
it has now become possible to control structure, materials, and
chemical functionality from the submolecular to the centimeter
scales simultaneously. Whereas substrates and surface functional-
ization have often been tailored to be resistant to bioadhesion,
deliberate placement of chemical patterns can also be used for
the growth and patterning of systems, such as bioﬁlms, to be put
into contact with nanoscale probes.177−180 Such methods in
combination with the tools of other ﬁelds (vide inf ra) will provide
the means to probe and to understand microbiomes.
Key tools for the microbiome will need to be miniaturized and
made parallel. These developments will leverage decades of work
in nanotechnology in the areas of nanofabrication,181 imaging
systems,182,183 lab-on-a-chip systems,184 control of biological
interfaces,185 and more. Commercialized and commoditized
tools, such as smart phone cameras, can also be adapted for
use (vide inf ra). By guiding the development and parallelization
of these tools, increasingly complex microbiomes will be opened
for study.167
Imaging and sensing, in general, have been enjoying a
Renaissance over the past decades, and there are various
powerful measurement techniques that are currently available,
making the Microbiome Initiative timely and exciting from the
broad perspective of advanced analysis techniques. Recent
advances in various -omics technologies, electron microscopy,
optical microscopy/nanoscopy and spectroscopy, cytometry,
mass spectroscopy, atomic force microscopy, nuclear imaging,
and other techniques, create unique opportunities for researchers
to investigate a wide range of questions related to microbiome
interactions, function, and diversity. We anticipate that some of
these advanced imaging, spectroscopy, and sensing techniques,
coupled with big data analytics, will be used to create multimodal
and integrated smart systems that can shed light onto some of
the most important needs in microbiome research, including
(1) analyzing microbial interactions speciﬁcally and sensitively
at the relevant spatial and temporal scales; (2) determining
and analyzing the diversity covered by the microbial genome,
transcriptome, proteome, and metabolome; (3) managing and
manipulating microbiomes to probe their function, evaluating
the impact of interventions and ultimately harnessing their
activities; and (4) helping us identify and track microbial dark
matter (referring to 99% of micro-organisms that cannot be
cultured).
In this broad quest for creating next-generation imaging
and sensing instrumentation to address the needs and challenges
of microbiome-related research activities comprehensively, there
are important issues that need to be considered, as discussed
below.
The Synthetic Biology Revolution. The microbial world
has been studied intensively since the invention of the
microscope. With the advent of molecular genetics, recombinant
DNA, and rapid DNA sequencing, many microbes are well
understood and form the core of both basic and applied bio-
logical research. We are now ready to reap the beneﬁts of this
investment, and synthetic biology is poised to fuel this future. In
broad strokes, synthetic biology provides the possibility of rapid,
systematic, and predictable engineering of the microbial world.
This includes the creation of microbes for varied purposes: (1) to
act as biological computers to sense and to respond to events in
their environment that cannot be directly observed; (2) to serve
as chassis for chemical engineering to produce molecules of
value more sustainably; (3) to produce new chemistries never
seen before; and (4) to create synthetic microbes with a genetic
ﬁrewall that prevents their genes escaping into other organisms
in the environment. Increasing our ability to program microbes,
especially in the context of complex microbiomes, will have vast
implications for human and global health.
Synthetic biology draws from investments in molecular
biology made over the past 50 years. Microbes provided the
basis for much of this work, which ultimately led to sequencing
the human genome, production of drugs such as human insulin
and antibodies, and the growth of the biotechnology industry.
Synthetic biology takes all of the prior knowledge to achieve
faster, more predictable, and ultimately cheaper engineering
of biology for the common good. The ultimate culmination of
these eﬀorts will be to synthesize entire microbial genomes that
will perform as predicted without undesired impacts on the
environment. Recent advances in the synthesis of DNAmake this
goal possible in the foreseeable future.
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Work at the Interface of Basic and Applied Research.
To impact economic development and the average citizen,
the microbiome initiative must support precommercialization
research. This is particularly important in areas where the ulti-
mate commercial product will require extensive and commer-
cially risky testing or where the science that would underpin such
a product is not yet established. Like other scientiﬁc revolutions
that have transformed our understanding of our place in the
universethe Copernican revolution that made us realize that
the Earth was not the center of the universe, the Darwinian
revolution that made us realize that we were one twig of life
among many, the Woeseian revolution that made us realize that
most of life’s diversity is microbial rather than contained in the
plants and animals we see around us as multicellular organisms
the implications of the microbiome revolution, that we are
outnumbered within our own bodies in terms of cell count and
vastly so in terms of gene counts, will take time to understand at
the level that permits far-ranging technological development.
However, we are now poised to make rapid progress with
appropriate investments in microbiome research.
Potentially ground-breaking areas include artiﬁcial micro-
biomesengineered consortia of microbes that work together.
One of the best methods of testing hypotheses about
microbiome function will be to try to mimic or to replicate
all or part of this function (vide inf ra). Exploring even a small part
of the phase space of microbiome and function will help in the
development of predictive understanding. As in other areas
of such multidimensional complexity, theory and simulation can
play critical roles in proposing key experimental tests of hypo-
theses and mechanisms, as well as in explaining observations.
Consequently, improved models at all scales, as well as bridges
across scales, such as appropriate quasi-static approximations, are
required, just as improved modeling has been critical for
understanding which materials in a vast search space are most
likely to have promising properties if synthesized.186
Microbial electrochemical technologies (METs) are examples
of such artiﬁcial microbiomes. Microbes have been used for
electrolysis, chemical production, and generation of electrical
power.187 In the future, these technologies may further be
coupled with photosynthetic microbes and produce or secrete
advanced biofuels or high-value chemicals and drugs. Microbial
fuel cells (MFCs) have been extensively researched but have not
yet produced a commercial product.188 Current MFCs suﬀer
from low power densities and small scales.189 Mechanistic
insight into microbe interactions with one another and with fuel
cell components remains elusive and hinders rational design
of MFCs. Intercellular electron transfer, extracellular electron
transfer (EET), and microbe electrode electron exchange are
processes that continue to elude comprehensive mechanistic
understanding.190
Extracellular electron transfer has been extensively studied
in bacteria of the genera Geobacter and Shewanella. Several
pathways have been proposed to explain how microbes move
electrons beyond their outer membranes. It may be that electrons
can be directly moved to or from an extracellular surface by
contact with outer membrane proteins, shuttled to targets by
secreted electron carriers, or transferred along the length of
bacterial appendages such as pili or membrane extensions.191,192
The design of microbial communities for maximal current output
is diﬃcult without understanding the EET pathway and the
microbial components involved. To test how electrons are
moved across length scales ranging from microns across bioﬁlms
to nanometers along individual cell appendages, nanoscience and
nanotechnology methods are needed. Manufacturing nanoscale
electrodes enables experiments to be performed that can probe
electron transfer within larger communities.193 Furthermore,
scanning probe microscopies such as conductive atomic force
microscopy and scanning electrochemical microscopy can be
used to measure individual parts of cells, and recent enhance-
ments enable measurements of key components of biological
structures.164,194,195
Cocultures of multiple species have been shown to produce
larger currents than any of the pure cultures in MFCs.189 Under-
standing the full community of microbes that power MFCs in
wastewater and benthic sediments will enable the eﬃcient design
of artiﬁcial microbiomes for energy production. Genome
synthesis and targeted editing allow a far easier entry method
for rapid engineering of microbes that have thus far only been
Figure 2. High-risk projects driven by synthetic biology include a
number of grand challenges, as follows. (1) Development of artiﬁcial
microbiomes that can safely live with a human or animal host. These
could, for example, make the use of antibiotics in farm animals
unnecessary and provide new classes of therapeutics. Such synthetic
microbes would become the gold standard in all of bioengineering.
(2) Development of a microbial consortium driven by light
collection that can produce commodity chemicals. This goal lies at
the center of the dream of harnessing our greatest natural resource
sunlightwhich Nature has accomplished but upon which we can
improve. (3) Development of microbes that can function beyond
biological systems in electronics, sensing, and nanotechnology.
Biology is good at production at the mesoscale, which has been
relatively refractory to bioengineers and chemists. Synthetic biology
aims to learn from Nature to produce novel useful molecular
structures to work at the interface between organisms and machines.
(4) Engineering at the interface between microbes and their hosts.
The same principles of synthetic biology can be applied to all cells,
including those of animals and plants, to program their interactions
with the microbial world for both discovery and applied research.
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sequenced but have not been cultivated, thereby drawing on
the vast potential of the entire microbiome. Techniques that
have primarily been used in homologous libraries can easily be
applied with genes from the environment when those genes can
be rewritten to optimize codon usage and other parameters for
expression in a standardized chassis.
Single-Cell Genomics. Mechanism-based understanding
of microbiome function (vide inf ra) and its interactions with
host cells requires detailed characterization of the organisms
that compose the microbiome, including their genetic contents.
Complete genomic analysis of the microbiome implies deter-
mining the complete genome sequence of each constituent
strain. Achieving this goal is technically challenging because
of the complexity of microbiome communities, which may
contain hundreds of operational taxonomic units (OTUs), the
wide ranges of organism abundances, distorted representation
of organisms in easily sampled ﬂuids, ﬁne-scale diﬀerences in
genomes196 that are functionally distinct but diﬃcult to identify
and to understand at the DNA sequence level, the diversity in
conditions required for culture,197,198 and lack of available
culture conditions for most organisms.
Single-cell genomics can productively contribute to the genomic
characterization of the microbiome, although technical improve-
ments to single-cell methods are needed for thesemethods to have
major impact on microbiome research.199 Standard approaches
to single-cell analyses involve the physical isolation of individual
microbes, lysis of each cell, and the ampliﬁcation of the cells’
genomic contents by whole-genome ampliﬁcation (WGA),
commonly multiple displacement ampliﬁcation (MDA).200
Single-cell genome sequences can be obtained directly from
crude samples to generate reference sequences for organisms
that are recalcitrant to laboratory culture.201,202 Such reference
sequences are valuable because they provide frameworks for
interpretingmetagenomic reads from these organisms and can be
used to validate binning approaches that aim to create composite
genome sequences directly from metagenomic data sets.203−205
Single-cell sequencing can be used to obtain sequence infor-
mation from rare community members in cases where analyses
can be targeted to these organisms.206
The high sensitivity of single-cell sequencing opens the
possibility of detailing the spatial structure of the microbiome,
which is lost in conventional genomic analyses. For example, single
cells obtained from microdissected tissues can be sequenced
and assigned to the microsample. This approach has been eﬀec-
tively applied in tumor analyses.207 An alternative approach to
resolving spatial information is the use of single-cell workﬂows on
small groups of physically associated cells to produce “mini-
metagenome”.208 The co-occurrence of sequences from diﬀerent
organisms in mini-metagneomic data sets implies physical and
functional association of those organisms, although care must be
taken to exclude technical contamination artifacts. Future in situ
single-cell analysis approaches may enable even higher resolution
of spatial relationships.
The rise of extraordinarily high-throughput DNA sequencing
makes comprehensive genomic analysis of the microbiome
theoretically possible by a number of diﬀerent approaches. In
principle, high-throughput analyses of cultured isolates and/or
single cells could be used provided that such isolates and/or
ampliﬁed single-cell samples could be obtained. If such samples
were available, the major challenges would be cost-eﬀective se-
quence library construction from such a large number of samples
and data analyses.
The major opportunities in single-cell analysis for microbiome
studies are streamlining experimental workﬂows, improving data
quality, and designing experiments that utilize single-cell data in
synergy with specialized sample collection methods and other
genomic analyses.
Currently available single-cell methods produce data quality
that is distinctly inferior to standard genomics methods. Early on,
contamination was a major impediment to single-cell analysis;208
extreme care remains critical to the production of contaminant-
free single-cell data sets.209 Typically, single-cell data sets enable
recovery of 10−60% of the genome due to the extremely uneven
ampliﬁcation of the genome by WGA.209 Another issue with
single-cell genomic data quality is the high frequency of chimeric
reads generated in WGA, which can dominate coverage at
speciﬁc loci.210−212 Chimeric reads interfere with de novo
analyses and analyses of horizontal gene transfer. In particular,
the high incidence of artifactual chimeras, commonly occurring
once per 5000 raw bases in single-cell MDA data, makes long-
read analyses of typical single-cell data useless.213 The coverage
bias and location of chimera artifacts are nonreproducible
from cell to cell, enabling substantial gains in genome coverage
and assembly contiguity if data from several closely related
cells can be pooled.199,214 Finally, techniques for analysis of RNA
(other than abundant rRNA) in single microbial cells are not yet
established,215 althoughmany groups are actively working on this
problem using strategies ranging from reducing the input
biomass in standard bulk protocols to using in situ sequencing
or probes for speciﬁc transcripts.
Signiﬁcant work on improving WGA chemistries is under-
way.199 To date, eﬀorts have focused on reducing ampliﬁcation
bias in mammalian cells to enable improved genome recovery
at lower sequencing eﬀort and to enable accurate assessment of
gene copy number. Today, WGA of microbial cells is performed
almost exclusively using MDA, with few exceptions,216 despite
the advent of alternatives that promise improved performance.217
Other work focuses on novel reaction formats for single-cell
WGA to improve throughput and data quality. There are two
ways to improve throughput for single-cell-resolved microbiome
analysis. The ﬁrst is simply to enable WGA of a larger number
of cells. The second is to preselect cells of interest for WGA,
which is functionally equivalent to higher reaction throughput
when subpopulations are of interest. Lab-on-chip-based micro-
ﬂuidic cell-sorting methods, including optical tweezers-based
approaches, can be used for cell selection based on observed
morphologies.204,206,218 Nucleic acid probes can be used to
identify cells based on lineage markers, although staining
protocols may further compromise data quality.219 Improved
approaches may apply nucleic acid probes toWGA products after
the ampliﬁcation reaction is complete. Microdroplet approaches
with the potential for very high throughput and/or improved
data quality are also being developed.216,220,221 In addition, there
are alternative approaches like in-gel ampliﬁcation that oﬀer
unique capabilities for single-cell studies.222
Despite extensive development of microﬂuidics for microbial
single-cell analysis by individual research groups, established
methods require specialized and/or expensive equipment, and
there is no commercially available system for microbial single-cell
genomics sample preparation.
Single-cell genomics ﬁlls important gaps needed to understand
the contents and structure of the microbiome. Single-cell geno-
mics may be the best way to characterize and to quantify micro-
biome composition at the strain level due to its high taxonomic
resolution and lack of culture bias. However, further improvements
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in data quality, throughput, and ability to target organisms
of interest are needed for single-cell genomics to make major
advances in microbiome research. In the intermediate term,
incremental advances in single-cell technology and improved
integration with other tools and approaches like advanced
analysis of metagenomic data and long-read sequencing will keep
single-cell analysis at the forefront of microbiome research.
Proteomics and Metabolomics. To characterize the
proteome and metabolome composition of myriad microbiomes
comprehensively will require transformative developments to
increase analytical sample throughput and biomolecule coverage
and the generation of computational tools necessary to analyze,
to integrate, and to visualize the obtained omics information.
Ultimately, improved analytics and analyses should lead to
tackling the ultimate goals of understanding microbial functions,
microbe−microbe and host−microbe interactions, networks,
and potentially the creation of predictive networks necessary to
manipulate and to control microbial systems.
A major limitation of current proteomics and metabolomics
capabilities is the need to compromise on either the scope of the
experiment or the completeness of the measurements. Another
signiﬁcant limitation is the capacity of software to handle large
volumes of data. Most mass spectrometry programs/algorithms/
software break down when trying to analyze even hundreds
of data ﬁles. Simple conversion of data in tab-delimited forms
(e.g., .mzML, .mzXML, or .MGF) so that data can be used easily
with third-party tools performs poorly, often slowly and with
errors. Batch processing requires skills at scripting. Similarly,
we lack good tools and appropriate scoring functions that can
address the complexity of the microbiome with proteomics. For
metabolomics, the reference spectra, some 300,000 in the public
domain covering some 20,000 spectra, do not cover microbial
chemistries well.223 Such limitations are areas of enormous
growth potential if we want to understand the function via the
molecular composition of the microbiome. To handle the vast
numbers of samples that will need to be analyzed to understand
microbiomes at the systems or population levels, traditional
liquid chromatography−mass spectrometry (LC-MS) platforms,
including the required analysis infrastructure, will need to be
optimized or completely changed to obtain rapid sample
throughput and high depth of coverage. A recent development
that is a signiﬁcant departure from traditional LC-MS is the
construction of structures for lossless ion manipulation.224 This
technology has the potential to enable high resolving power in
ionmobility separations, which exceed the resolving power of LC
separations, and that in conjunction with MS-based platforms
may increase sample throughput by as much as 100-fold.
An additional LC-MS-based improvement with the potential
to improve metabolomics and proteomics analyses greatly is
multidimensional high-throughput separations for analyzing
distinct ion characteristics simultaneously in a single analysis.
Multidimensional separations can increase the overall measure-
ment separation power, resulting in greater information content
and more complete characterization of the complex samples.225
It is also important to make the data interpretable for the
end user. Data visualization is critical for understanding, and this
need has only begun to be addressed for mass spectrometry.
For example, the development of fragmentation trees for
subclassiﬁcation of chemistries,226 cloudplots,227 structural
classiﬁcation-based networking,228 and molecular networking229
will all make it easier for us to understand the data that are
collected by mass spectrometry and other means. Visualization is
critical for complex data sets. Although many improvements are
needed to develop these capabilties in a common methodology,
microbial imaging mass spectrometry has seen enormous
advances.230 Microbial imaging mass spectrometry can detect
molecules, or fragments of molecules, at resolutions from 30 nm
to millimeters. Imaging mass spectrometry of germ-free mice
colonized with B. theta. or B. longum revealed how these bacteria
are needed for the metabolism of complex carbohydrates,
altering the immune system as evidenced by the increase in
prostaglandin E2 and how they actively create new bile acid
derivatives (Figure 3A). Three-dimensional cartography expands
this range to centimeters, as shown for human skin (Figure 3B),
and can be readily adapted to global scales.231 The speed of
technology development for omics analyses is rapid, and the next
steps for microbiome research are to use new technologies
Figure 3. Representative examples of imagingmass spectrometry and
3D cartography. (A) Matrix-assisted laser desorption/ionization
time-of-ﬂight (MALDI-TOF) mass spectrometry image of bile acid
metabobolism by B. theta and B. theta/B. longum. Upon colonization,
primary bile acids increase in concentration, speciﬁc bile acids have
speciﬁc distributions, and the microbes actively metabolize bile
acids. (B) Three-dimensional cartography of the surface of human
skin. The signals shown are representative metabolomics masses
detected in the experiments.
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eﬀectively to answer complex biological questions. Critically,
the massive scale of data to be generated from these new
technologies will challenge current bioinformatics capabilities.
For example, we can currently only annotate less than 2% of
the data that are collected in metabolomics experiments; com-
putational solutions are key to overcome this annotation
challenge.232−234 New software and algorithms will be required
to compile data sets, to overlay multi-omic analyses, and to
visualize and to communicate important networks, interactions,
functions, and other biological phenomena to emerge from
the data. To our knowledge, at present, the only metabolomics
analysis infrastructure where a large portion of the analysis
is performed on microbiome data sets is the Global Natural
Products Social Molecular Networking (GNPS),235 a crowd-
sourced analysis infrastructure.
Opportunities for Functional Microbiome Character-
ization by Activity-Based Protein Proﬁling. Considerable
challenges exist in determining the functional roles of human
microbiomes or complex microbial communities in the environ-
ment. Due to the intrinsic complexity of these systems, the
majority of our mechanistic insights into microbiomes and their
enzymatic functions are either inferred from genomic sequence
data or derived from experimental evidence using a relatively
small number of culturable model organisms. More recently,
metatranscriptomic data have been used to evaluate gene
expression of the “active” fraction of microbiomes, provid-
ing greater insight into their potential aggregate functional
capacities.236,237 To advance our understanding of the functions
of microbiomes, innovations in analytical approaches are needed
that permit identiﬁcation of the speciﬁc proteins associated with
a given biochemical activity. Such innovations could, for instance,
pave the path toward rational approaches to manipulate the
human microbiome for therapeutic advantage or construct syn-
thetic microbiomes to facilitate bioenergy production or bio-
remediation processes.
Activity-based protein proﬁling (ABPP) is a powerful chemical
biology approach with the capacity to elucidate understanding of
the speciﬁc protein activities that comprise a given microbiome
phenotype. In ABPP, synthetic activity-based probes are used to
report directly on protein function, regulation, and protein−
small-molecule interactions within the native physiological
context of systems under study. The probes target metabolite-
binding sites of proteins (enzymes, transporters, or regulators)
rather than DNA or RNA sequence, and thus their design is not
constrained by sequence similarity or prior knowledge of DNA
sequence, allowing identiﬁcation of a broad variety of microbial
organisms with the desired functional attributes. Speciﬁcally,
probes can be developed to address: (1) targeting of enzymes
with speciﬁc metabolic functions;238 (2) chemical probes that
mimic natural compounds, such as natural products or
metabolites, that selectively label cells able to utilize the natural
compound and bind to transporters and other proteins
(enzymes, regulators) that are involved in metabolite detection,
salvage, and disposition; and (3) probes that target protein
regulator modiﬁcations, such as protein thiol redox events.239
The probes consist of three elements: (i) a reactive group that
forms an irreversible covalent bond with a target protein via
direct catalytic reaction or photoreaction, (ii) a binding group
(e.g., protein substrate or metabolite) that biases a probe toward a
protein or protein family and may also impart cell permeability,
and (iii) a reporter group such as a ﬂuorophore or biotin for
enrichment and subsequent proteomic characterization. Alter-
natively, several studies employ probes containing an alkyne or
azide moiety to enable the bio-orthogonal “click” chemistry
reaction that permits the addition of a reporter tag following
in situ or in vitro probe labeling; this chemistry also facilitates
the facile exchange of reporter types applied based on the desired
application and outcome of the study and properties of the
sample being assayed.
To date, ABPP has been applied to a diverse array of cultured
microbes, from pathogenic organisms such as Mycobacterium
tuberculosis and Staphylococcus aureus to cyanobacteria.240
However, application to complex uncultivated microbiomes
has yet to be reported; these challenges include optimizing
sample labeling and processing, obtaining genomes or meta-
genomes representative of the microbiomes under study to be
used for proteomic data analytics, and challenging analysis.
However, these challenges are representative of microbiome
proteomic analyses in general and need to be overcome to enable
comprehensive omic studies. Despite challenges, ABPP has
signiﬁcant potential to play key roles in resolving spatiotemporal
microbiome dynamics by imaging and proteomics, in character-
izing functional responses due to microbiome perturbation by
the environment or host, and in translating genomes or meta-
genomes directly to functional proﬁles. Coupled to improved
omic and imaging strategies, ABPP will be important to the
functional characterization of microbiomes.
Multiscale Multi-Omics. Functional testing at the ecosys-
tem rather than the enzyme level is not yet possible. Subsets of
data are accessible. Examples from diﬀerent ﬁelds include bio-
reactors, where concentrations of diﬀerent chemicals and gases
can be tracked, the gut, where nutritional and physiological status
of the host animal can be assessed, and for soils, where direct
turnover measurements or the nutritional and physiological
status of plants can be determined. At larger scales, one could
apply this concept to aqueous environments to deﬁne ocean or
lake health. Understanding the emergent function of microbial
ecosystems remains an unsolved challenge but is a target of this
initiative.
To understand the function of the microbiome in diﬀerent
habitats, it is necessary to look across diﬀerent spatial and
temporal scales as well as to determine function at diﬀerent levels
of expression. Genome and metagenome data are valuable
for making predictions about potential functions. However,
not all genes are expressed and translated to proteins under
all conditions. To assess function more directly, one could use a
multi-omics approach. The combination of 16S rRNA gene
sequencing, metagenome sequencing, metatranscriptome se-
quencing, metaproteomics, and metabolomics has been referred
to as an “omics information pipeline” (Figure 4).241 Each step
along the omics pipeline provides diﬀerent details as to potential
function or expression. For example, a multi-omics approach
was recently used to determine the impact of permafrost thaw
on microbial community processes.242 In this study, the ratio
of genes in the metatranscriptome to metagenome was used to
assess relative levels of expression and activity of speciﬁc species
To understand the function of the
microbiome in diﬀerent habitats,
it is necessary to look across diﬀerent
spatial and temporal scales as well as
to determine function at diﬀerent levels
of expression.
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and functional genes in permafrost samples, compared to seasonally
thawed-active layer samples and to a completely thawed
thermokarst bog.
Another example of the use of a multi-omics approach was
the use of 16S sequence analysis,243−245 metagenomics and
proteomics,246 and metabolomics16 to study twins that were
discordant for Crohn’s disease. In this series of studies, the exact
same fecal samples were analyzed using diﬀerent omics
approaches. There were consistent diﬀerences between healthy
and diseased individuals for all of the data sets, including
lower diversity, depletion of Faecalibacterium prauznitzii, and
lower levels of proteins involved in butyrate metabolism by
F. prauznitzii in individuals with Crohn’s disease inﬂammation
in the ileum. Additionally, at the metabolite level, there were
thousands of metabolites that diﬀerentiated healthy from
Crohn’s disease, including a higher amount of bile acids in the
diseased individuals.247 However, the majority of the metabolites
could not be identiﬁed, highlighting the need for better
understanding of and databases for metabolomics.
After the Deepwater Horizon oil spill in the Gulf of Mexico,
samples were taken from a deep plume of oil in the water column
and analyzed by a combination of sequencing technologies,
including 16S, metagenome, metatranscriptome, and single-cell
sequencing.248 The combined results revealed shifts in structure
of the microbiome, shifts in transcription toward alkane
degradation in the plume, as well as draft genomes of potential
hydrocarbon-degrading members of the community.
A multi-omics approach has also been applied to the charac-
terization of the complex molecular mechanisms employed in
host−pathogen−commensal interplay during Salmonella intesti-
nal infections.249 Proteomics, metabolomics, metagenomics,
and glycomics were used to reveal the dynamic disruptions to
the intestinal microbial population and metabolite proﬁle as a
result of Salmonella enterica serovar Typhimurium infection. The
emergent application of multi-omics strategies to microbiome
research will continue to have signiﬁcant impact, but bottlenecks
remain in omics strategies. For instance, proteomics requires
annotated genome ﬁles to associate experimental spectra to
theoretical spectra for peptide/protein characterization. Metab-
olomics requires spectral libraries and metabolite standards for
high-ﬁdelity identiﬁcations. Several groups are addressing these
and other challenges, thereby increasing the individual and com-
bined utility of omics approaches.
Multiscale Imaging and Functional Measurements.
Discovery-based approaches, such as microbial genomics, have
been revealing the composition of the microbiome.250 How-
ever, there remains a great need to deﬁne precisely the roles and
nanoscale relationships of each member of a microbial
community. To understand the interactions that make up the
complex ecosystems in our bodies and our environment, these
communities now need to be understood at the molecular scale.
This advance will require the development of new tools for
investigating the function of molecular processes within
microbial communities.251 Molecular-scale imaging can provide
dynamical information fromwhich to infer function. This cellular
and subcellular appreciation will yield insight into human health
and disease and enable advances from personalized medicine to
control the human microbial community to engineering the
ecology of natural and built environments.
Optical microscopy is a direct, noninvasive technique that can
attain real-time information about microbial communities. Thus,
imaging stands to have wide-ranging impact in the study of the
microbiome. On the scale of thousands, millions, or more
microbes, imaging will answer questions in real time about
membership and spatial organization of cells in communities,
about heterogeneity, and about diversity. A generalizable method,
imaging promises to elucidate the cellular density and composition
in water, on land, and within the body. On the single-cell and
subcellular scale, imaging will ﬁll in gaps in our knowledge about
the biochemistry of microbiome members. Important questions
will be answered, for instance: how do bacterial cells communicate
with one another and with their host? How do microbes perform
symbiotic functions like nutrient metabolism? How do cells
communicate with and react to their physical environment?
Challenges of Imaging the Microbiome. The challenges
of imaging the microbiome will push the limits of imaging
technology. In particular, the community is of the utmost
importance to the microbiome. Although models can be useful,
communication between cells and interactions with the environ-
ment cannot be ignored. This community is not two-dimen-
sional; complete, thick, three-dimensional (3D) assemblies must
be considered, whether in animal hosts or in soils. Imaging the
microbiome is therefore an inherently multiscale problem in
both time and space. Visualizing the microbiome will require an
arsenal of tools at diﬀerent levels, frommolecular-scale single-cell
studies of prototypical microbes to large-scale, high-throughput/
low-resolution techniques. Overall, new imaging tools need to be
Figure 4. Various stages of the multi-omics pipeline provide diﬀerent levels of information.
Each step along the omics pipeline
provides diﬀerent details as to potential
function or expression.
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developed to resolve 3D materials in real time and to handle
thick, opaque samples, including soil and tissue. Indeed,
development of some of the needed imaging technology can
beneﬁt from solutions to other complex problems such as those
being addressed in neuroscience.168
Imaging Technologies. Fluorescence and transmission
microscopy are noninvasive methods ideally suited to resolve
the dynamical processes in microbial communities. Confocal
microscopy can achieve ideal diﬀraction-limited resolution,
enabling optical sectioning and cell-level resolution. Still, optical
microscopy is traditionally limited in its ability to visualize
molecular-scale details and to probe inside bacteria cells. Super-
resolution imaging has therefore been recognized as having the
power to revolutionize biology.252 In particular, single-molecule
ﬂuorescence tracking and imaging are sensitive to low copy
number proteins, can disentangle heterogeneous behaviors, and
bring the advantages of ﬂuorescence microscopy to the high-
resolution regime by enabling live-cell imaging with nanometer-
scale resolution in conventional ﬂuorescence microscopes.253
Single-moleculemicroscopy has been extended to three dimensions,
and modern developments based on adaptive optics, two-photon
microscopy, and lattice light sheets now bring high-resolution
imaging even to deep-tissue imaging.254,255
Labeling Technologies. Developments in protein-labeling
technology will be important as we work toward the challenge of
ﬂuorescent imaging in the microbiome. Fusions to intrinsically
ﬂuorescent proteins are the traditional workhorse of optical
microscopy, but these do not extend to the red, making it diﬃcult
to multiplex more than two ﬂuorescent protein colors in high-
sensitivity applications.256 Furthermore, the chromophore in
traditional GFP derivatives require oxygen to mature, making
them unsuitable choices for imaging living anaerobic cells,
such as most gut bacteria.257 Enzymatic labeling systems like
HaloTag258 provide a useful alternative for speciﬁc covalent
linkage of small molecules, and these have been used to label
speciﬁcally a prototypical starch catabolism protein, the SusG
α-amylase, in the prominent gut symbiont Bacteroides
thetaiotaomicron.259 Looking forward, unnatural amino acid
labeling is a promising way to tag proteins ﬂuorescently in a less
perturbative way, although this labeling scheme has not yet been
demonstrated for single-molecule ﬂuorescence applications.260
Although protein-labeling methodologies are now well-
established for ﬂuorescence and super-resolution microscopy,
there remains an important need for ﬂuorescent labeling
techniques that are suitable for high-resolution, high-sensitivity
imaging of other biomacromolecules. Beyond protein imaging,
molecular-scale characterization of bacterial cell biology re-
quires the identiﬁcation of protein−gene interactions to
elucidate regulatory responses. These can be inferred from
gene knockouts,261,262 and new technologies based on a repur-
posed CRISPR/Cas system nowmake it possible to label speciﬁc
genetic loci directly.263 Furthermore, ﬂuorescent or ﬂuorogenic
probes for visualizing small molecules will be important to eluci-
date communication. Recently, Karuntilaka et al. demonstrated
that the prominent human gut microbiota member Bacteroides
thetaiotaomicron could grow on ﬂuorescently labeled starch,
allowing nanoscale detection of the mechanism of starch
recognition.259
Model Systems To Aid in Small- and Intermediate-
Scale Studies of the Microbiome. Because of the multiscale
dynamics of the large-scale microbiome, community-level studies
will need to be complemented by high-detail, high-resolution
examinations of model systems. Fortunately, such model systems
exist, for instance, the prototypical starch utilization system (Sus)
in B. thetaiotaomicron,264 which has tractable genetics and can be
manipulated in culture or in mice.265 Such studies have yielded
tremendous insight into how diet shapes the composition of the
human microbiome.266 Larger scale, yet microbiologically
manipulatable and transparent models like zebraﬁsh provide
interesting opportunities, in particular, for investigating mech-
anisms leading to intestinal injury and inﬂammation.267,268
Finally, engineered environments such as mimic soils, epithelial
monolayers,269 and synthetic bioﬁlms270 provide well-controlled
substrates that create simpliﬁed models of natural environments
and host associations.
Another class of model microbiomes is that provided by plants
and invertebrate animals that have beneﬁcial symbioses with
one or a few species of bacteria. The longest and best studied of
these associations is that between nitrogen-ﬁxing bacteria and
leguminous plants,271 which have provided great insight into
areas as diverse as the chemistry of cell−cell signaling and the
mechanisms of coevolution. More recently, a number of natural
invertebrate models have begun to produce similar insights
into the principles governing bacterial−animal microbiomes.
The phylogenetic diversity of these associations is exceeded
only by the breadth of biological questions they have opened to
investigation (Figure 5). Like nitrogen-ﬁxing symbioses, the
monospeciﬁcity of the microbiome present in the biolumines-
cent organ of sepiolid squids has made possible fundamental
discoveries like quorum signaling in a beneﬁcial symbiosis272 and
provides a window into the experimental manipulation of
population-level diversity in a microbiome.273,274 In the past few
years, studies of a number of simple consortia such as those
present on the surfaces of hydra275 and within the guts of leeches
or honey bees276,277 have begun to reveal the mechanisms of
immunological and physiological communication between a host
and its microbiota. Taken together, these simple, but natural,
microbiomes have proven remarkably useful in providing
windows into the workings of more complex and diﬃcult to
study consortia like that in the mammalian gut. For example,
the roles of bacterial envelope molecules in inducing tissue
development or of symbiont modulation of circadian rhythms
were discovered in invertebrate model symbioses278 and led
to the recognition that bacteria regulate similar activities in
the gut.279,280 We have only begun to learn how natural, but
simple, animal symbiotic systems will yield insight into how
microbe−host and microbe−microbe interactions underlie
microbiome function. The small sizes of invertebrate micro-
biomes will make them important platforms upon which to
develop and to apply nanotechnologies that enable microbial
Figure 5. Examples of simple model symbioses for microbiome
research.
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community manipulation, chemical analysis, imaging, and other
modes of investigation.
Synergies with Biology, Biochemistry, Spectroscopy,
and Bioengineering. While imaging can provide high-
resolution, real-time, 3D glimpses into the microbiome, these
images and tracks can be assigned function only through inte-
gration with data from biology and biochemistry. Importantly,
structural biology, which achieves atomic resolution, can probe
the in vitro structure and binding sites of microbiome
proteins.281,282 This in vitro snapshot can then provide a context
for the less tidy information that comes from live-cell and in vivo
imaging.259 Optical microscopy can also be easily integrated with
other imaging methods, including electron tomography of cells
and organisms, atomic force microscopy of surfaces, and X-ray
tomography. Overall, synergy between biophysical and optical
tools and cell biological approaches is needed to explore the
molecular-scale aspects of the microbiome.283
Assigning function to microscopic data will further require
spectroscopy and other functional assays. Comprehensive
understanding of the molecular-scale behavior of microbiomes
will therefore be achieved only by multiplexing functional and
imaging data, for instance, by correlating images with readouts
for nutrient uptake, communication, and quorum sensing. Such a
large-scale eﬀort will need to take advantage of computation and
data repositories, and indeed, these applications will pose signiﬁcant
challenges that may motivate new computational approaches.
Applying State-of-the-Art Microscopy to Questions
about the Microbiome. The human gut microbiome plays
key roles in health and nutrition by metabolizing many host-
indigestible carbohydrates. Indeed, the ability to recognize and to
process carbohydrates strongly inﬂuences the structure of the gut
microbial community. Karunatilaka et al. used nanometer-scale
super-resolution imaging to explore the transient interactions,
assembly, and collaboration of the proteins involved in starch
processing by the starch-utilization system (Sus) in the
prominent human gut symbiont Bacteroides thetaiotaomicron in
real time and in live cells.259 This project brought molecular-scale
understanding to this aspect of the humanmicrobiome, as well as
demonstrated the power of single-molecule imaging of living
anaerobes. Protein ﬂuorescent labeling was performed based
on information from X-ray crystallography about the structure of
the α-amylase SusG (Figure 6a) and the SusG starch-binding
site (Figure 6b).284 Live-cell super-resolution imaging, single-
molecule tracking (Figure 6c), simultaneous monitoring of starch
and protein moieties (Figure 6d,e), and Sus protein knock-
out strains provided unique mechanistic insights into a glycan
catabolism strategy that is prevalent within the human gutmicrobial
community. Overall, the results from this study provided a working
model of Sus complex assembly and function during glycan
catabolism and are likely to describe aspects of how other Sus-like
systems function in human gut Bacteroidetes within the human gut.
On the organism scale, another state-of-the-art imaging tech-
nique, light-sheet microscopy,285 has been used to visualize the
colonization of a live, vertebrate gut by speciﬁc bacteria with
suﬃcient resolution to measure activity over a population range
from a few individuals to tens of thousands of bacterial cells.268
By acquiring 3D images of living, initially germ-free zebraﬁsh
larvae inoculated with ﬂuorescently labeled strains of Aeromonas
bacteria over the course of several hours (Figure 7), the authors
quantiﬁed bacterial growth kinetics, ﬁnding that the average
Figure 6. Molecular-scale depiction of starch catabolism in gut symbionts is derived from single-molecule imaging and structural biology. (a) X-ray
crystal structure of the prominent gut symbiont Bacteroides thetaiotaomicron starch utilization system α-amylase protein SusG. Ribbon diagram of
SusG, colored by domain. Metal ions are displayed as orange spheres, and likely ethylene glycol molecules are in light green. The locations of
maltoheptaose molecules bound to the active site, to the secondary starch-binding site, and to the carbohydrate-binding module CBM58 are
represented bymauve, green, and gray spheres, respectively. (b)Malto-oligosaccharide bound to the active site of SusG. Electron density from an omit
map at the SusG active site of the SusG-D498Nmutant cocrystallized withmaltoheptaose. The electron density is contoured at 3 s, and the stickmodel
of the bound oligosaccharide is colored according to atom type. (c) Single-molecule trajectories of SusG-HaloTag-tetramethyl rhodamine (SusG-HTL)
in glucose (random colors) reveal that the starch utilization protein SusG diﬀuses heterogeneously on the B. thetaiotaomicron outer membrane.
(d) Single-molecule tracks show conﬁned movement of Alexa 488-labeled amylopectin (AP-Alexa 488) bound to a cell. (e) Time-dependent single-
molecule tracks of SusG-HTL in starch show high conﬁnement of SusG at the position of AP-Alexa 488 (arrow). Panels a and b reproduced with
permission from ref 284. Copyright 2010 Elsevier. Panels c−e reproduced with permission from ref 259. Copyright 2014 Karunatilaka et al.
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population growth followed a logistical model. Furthermore, the
cell-level resolution of this method uncovered heterogeneities
that would be masked by ensemble measurements. In particular,
by resolving the spatial and temporal dynamics of the bacteria,
these cells were found to be nonuniformly distributed through-
out the gut, and bacterial aggregates were found to grow con-
siderably faster than discrete individuals. These results highlight
the importance of acquiring cell-level maps to predict host−
microbe interactions and suggest that single-organism-level spatial
characterization will help to describe host-associated microbial
community assembly.
Bacteria in bioﬁlm communities are phenotypically distinct
from those in isolated, free swimming form; thus, new strategies
for experimental characterization of these phenotypes will
provide a powerful complement to genome-based and tran-
scriptome-based approaches. Multidisciplinary approaches will
be important since the new tools will be both experimental and
conceptual.166 While much has been learned, we are reaching
the limits of traditional bacteriological methods since bioﬁlm
development depends strongly on epigenetic and communal
factors such as individual responses to chemical gradients,
proximity of neighbors and neighbor behavior, and heterogeneity
of signals. For example, super-resolution microscopy can be used
to delineate the distinguishable individuality of each cell in a
community, as well as the heterogeneous environments that are
created and felt by each cell, as exempliﬁed in recent work on
Vibrio cholerae.169
Present technology enables either analyses of only a small
number of cells or analyses of entire cell populations that have
been removed from the conditions of interest. Because bacteria
in growing communities often display multiple phenotypes that
are not discerned when observed collectively, what is needed are
methods that track the behavior of individual cells at the
community level. Recently, massively parallel techniques have
been developed to track single-species assemblages at single-
cell resolution.286,287 Movies of bacteria imaged by microscopy
are translated into full histories of individual cells and searchable
databases of behavior, so that the information content extracted
is ∼100,000× greater than that from traditional methods. These
methodsmust be generalized to addressmultispecies communities.
Examples of symbiosis within microbial consortia demonstrate
the importance of motility in the self-assembly of these mixed-
species assemblages. However, we will also need to generalize
our experimental techniques to create surveillance systems for
tracking lineage, signaling, and secretion, in addition to motility,
so that we can determine how dynasties of cells of a given species
interact with themselves and with others. A step in the right
direction can be seen in recent work on combinatorial ﬂuorescent
labeling that combines confocal imaging with spectrometry.288
While traditional ﬂuorescence in situ hybridization traditionally
only labels a small number of phylotypes in a community, the array
of ﬂuorescent signatures that can be deconvoluted from a single
microscopy image has been expanded by using binary combi-
nations of ﬂuorophores. Using combinations of genus- and family-
speciﬁc oligonucleotide probes targeted to microbial rRNA,
15 diﬀerent taxa in human dental plaque were simultaneously
imaged and analyzed.288
Sample Preparation and Multimodal Imaging for
Advanced Analysis. Sample preparation is an important
element that will determine the overall complexity and success
of a given imaging or sensing instrument and its application to
microbiome-related analysis and characterization. In cases where
destructive or invasive sampling and analysis are acceptable,
various mainstream labeling and sample preparation strategies,
including ﬂuorescence or isotope-based labels and multiplexed
micro- and nanoﬂuidic systems, can be utilized to bring sensi-
tivity and speciﬁcity to detection and tracking of various chemical
signatures to probe, for example, genes, enzymes, metabolites,
etc. Recently developed ﬂuorescence microscopy/nanoscopy
super-resolution techniques such as photoactivated localization
microscopy (PALM),289 stochastic optical reconstruction micros-
copy (STORM),290 stimulated emission depletion microscopy
(STED),291 structured illuminationmicroscopy,292 and light-sheet
microscopy293 will ﬁnd critical uses in revealing spatial and
temporal dynamics of nanoscopic processes within single micro-
organisms.253,294−296 On the other hand, there is also an important
need to create nondestructive or minimally invasive sampling
interfaces without altering the natural habitat of the microbiota,
and these types of imagers and/or sensors will need to be mostly
label-free and require minimal front-end processing before a
measurement is performed. For label-free systems, speciﬁcity can
still be achieved by various means, through, for example, endo-
genous contrast mechanisms (which can be read, e.g., by Raman
spectroscopy,297,298 autoﬂuorescence imaging,299,300 multispectral
imaging,301 optical scattering302,303) for 2D and 3Dmorphology as
well as motion. The latter can be especially interesting for the
analysis of airborne and waterborne microbiomes and would be an
exciting research direction to create fundamentally new imaging
designs that utilize motion as a key signature for microbiome
analysis.
Measurement Throughput and Sampling Volume. The
spatial and temporal throughput of imaging and sensing
technologies is important, especially if the diversity of microbial
communities is large and their spatiotemporal patterns are not
known. Multimodal and advanced microscopy/nanoscopy and
Figure 7. Growth kinetics of a microbial species in the zebraﬁsh gut
monitored in vivo by light-sheet microscopy. (A) Image of a larval
zebraﬁsh 5 days postfertilization, with the intestine shown by phenol
red dye (red). Scale bar: 250 μm. (B) Maximum intensity projection
(MIP) at 1.6 h postinoculation of the initially germ-free zebraﬁsh
with Aeromonas veronii. Several individual bacteria are visible, and
the inset shows a magniﬁed view of a single bacterium (inset width:
22 μm). White bars indicate autoﬂuorescent sources from the
zebraﬁsh host. Scale bar: 100 μm. (C) MIP of the same ﬁsh as shown
in (B) at 9.1 h postinoculation, showing a large bacterial population
at this time point. Scale bar: 100 μm. Orientation of all images is
anterior to the left and dorsal to the top of the panel. Reprinted with
permission from ref 268. Copyright 2014 Jemielita et al.
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spectroscopy tools, although extremely powerful with their
multidimensional information, tend to be low throughput and
can only probe rather small ﬁelds of view or sample volumes.
This limitation can potentially be addressed by some of the
emerging computational imaging and sensing techniques, which
can analyze orders of magnitude larger volumes by using lens-free
on-chip designs,304 where the sample volume and ﬁeld-of-view
are dictated not by optics or lenses, as in the case of traditional
imaging designs, but by the active area of an optoelectronic
sensor chip, which can easily reach 10−20 cm2 using modern
CCD and CMOS technologies. Another interesting advantage of
such computational imaging and sensing tools, over their
traditional counterparts, is that they can also be made
signiﬁcantly more cost-eﬀective and ﬁeld-portable, which opens
up opportunities currently beyond the reach of traditional
advanced laboratory-grade imaging and analysis tools.305
Field-Deployable and Ubiquitous Imaging and Sens-
ing Tools. For decades, microscopy has been the workhorse of a
number of ﬁelds including medicine and biology. Over the past
few years, however, cost-eﬀective and compact microscope
designs were developed such that even mobile phones could be
converted into advanced microanalysis tools, capable of
detecting single viruses or bacteria, conducting blood count,
measuring molecular signatures of diseases in bodily ﬂuids, high-
resolution imaging of histopathology slides, malaria smears,
among many others.306−312 All of these mobile imaging, sensing,
and measurement interfaces beneﬁt from economies of scale,
mostly due to mobile phones and other consumer electronics
devices, and through these emerging platforms various imaging
and sensing tasks that are normally performed in advanced
laboratories can now be performed in ﬁeld settings in extremely
cost-eﬀective ways.313 Another dimension of this exciting
development is that it opens up new opportunities for citizen
scientists to make meaningful contributions to microbiome
research. In other words, through these simple, cost-eﬀective,
ubiquitous, but powerful interfaces that now give interested and
engaged citizens sensitive and speciﬁc measurement capabilities
at the micro- and nanoscales, we are likely to see massive
increases in the numbers of useful measurements that sample
various microbiome-related signals.
Once successfully scaled up, this smart network of micro-
scopes, measurement tools, and their users (i.e., professional
scientists as well as citizen scientists) could deliver an
extraordinary bounty of microbiome data through innovative
uses of this network and its expanding database. For instance, by
creating massive libraries of various microbial communities,
parasites, viruses, etc., we can dynamically track the spatiotem-
poral evolution of diﬀerent micro-organisms and investigate and
identify the cause−eﬀect relationships of these patterns at large
scales. Such a network of microscopes and related databases
could be a priceless global asset for research and for microbiome-
related applications for both the developed and the developing
world. On the other hand, one important potential challenge
toward this vision is handling such large-scale data and creating
standardized interfaces and repositories, as discussed below.
Precision Tools for Manipulating Microbiomes. In the
context of naturally occurring microbiomes of high complexity,
determining the roles of speciﬁc microbial species, biovars, genes,
and gene products in community function is critical and will
require tools for precise manipulation. Ideally, these tools would
be useful for studying microbial communities in diverse
environments, from agricultural soils to gingival pockets, but
niche-speciﬁc approaches are also of value. A toolkit for deleting,
adding, or genetically modifying speciﬁc microbes in situ, alone
and in combination and without the need for prior cultivation,
would be of extraordinary value. In addition to their utility for
interrogating and managing microbiota, a subset of these tools
could provide new approaches for treating infectious diseases in a
way that reduces selection for transmissible resistance and leaves
beneﬁcial microbes unharmed (see Box 2).
Design features for a precision antimicrobial capable of
ablating speciﬁc members of a diverse microbial community
in situ include (1) high speciﬁcity, deﬁnable at the species, strain,
biovar, or other relevant level and (2) high eﬃciency, which
includes gaining access to target cells in natural environments
and killing activity upon arrival. Although still at an early stage,
two approaches for engineering precision antimicrobials have
shown eﬃcacy in model systems of human disease. The ﬁrst is a
speciﬁcally targeted antimicrobial peptide (STAMP) that
consists of a targeting sequence fused to an antimicrobial peptide
(AMP). A STAMP called C16G2 selectively kills Streptococcus
mutans, which is a predominant cause of tooth decay.314 For
C16G2, targeting is conferred by a 16 amino acid sequence
derived from a strain-speciﬁc bacterial pheromone, competence-
stimulating peptide, fused to a 16 residue broad-spectrum AMP
designated G2. In an in vitro, saliva-derived bioﬁlm model
containing over 100 species representative of the diversity of the
human oral microbiome,315 C16G2 showed impressive anti-
microbial activity against S. mutans, decreasing average
abundance from 24 to 0.1%. A corresponding community-level
shift in species composition and abundance was also observed.
Although likely due to the ecological consequences of elimi-
nating a predominant member of the multispecies bioﬁlm,
further studies are needed to determine if the broad spectrum of
the G2 AMP also results in some level of oﬀ-target killing.
Nonetheless, this is a promising approach for an anticaries
drug, and STAMPs may provide broadly applicable tools for
engineering microbiomes in other environments.
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Another strategy for designing precision antimicrobials is
based on contractile nanotubes, ubiquitous tools used to pene-
trate bacterial surfaces in nature, often with exquisite speciﬁcity
and eﬃciency. Their utility is greatly expanded by the ability to
engineer speciﬁcity for diﬀerent cell-surface receptors, combined
with a generic mechanism of cell penetration. Myovirus bacterio-
phages, exempliﬁed by phage T4, use contractile injection
systems to translocate DNA into bacterial cells.316 An adaptation
of the same contractile mechanism is used by numerous bacteria
to kill competitors, with the best studied example being the
R-type bacteroicins produced by Pseudomonas aeruginosa.317 In
contrast to phage, these function as bactericidal particles by
inserting ion-conducting channels across the envelopes of target
bacteria. A recent cryo-transmission electron microscope (cryo-
TEM) analysis of pre- and postcontracted particles provides a
model for contraction that likely applies to ejection systems used
by phage, bacterial type-VI secretion systems, and other related
machines.317 The contractile nanotube shown in Figure 8
consists of an outer sheath surrounding a hollow inner tube. The
precontracted particle is assembled into a high-energy, meta-
stable state in which sheath and tube proteins interact through
charge complementarity. Contraction initiates when tail ﬁbers,
which are disordered and not resolved by cryo-TEM, bind to
cognate receptors on bacterial cell surfaces. This recognition
initiates a cascade of events that results in translational move-
ment of sheath subunits that are intertwined by β-sheet
augmentation. During contraction, the sheath increases in width,
decreases in length, and electrostatic interactions between sheath
and tube proteins are broken. The released energy powers the
injection process, which occurs in the absence of ATP. In many
cases, a single R-type bacteriocin is suﬃcient to kill a bacterial cell.
The ability to retarget bacteriocin speciﬁcity by substituting
ligand-recognition domains of receptor-binding proteins (RBPs)
from phage or other contractile bacteriocins has been demon-
strated in multiple studies.318−320 Since bacterial genomes are
often replete with prophage sequences, the ability to culture a
particular organism may not be required to design a precision
ablating tool if suﬃcient genome sequence information is
available.321 Although the bactericidal spectrum of the structure
shown in Figure 8 is likely conﬁned to Gram-negative species,
Gram-positive bacteria produce analogous bactericidal structures
that can also be retargeted by substituting RBPs. The utility of
this approach was recently demonstrated in a mouse model of
antibiotic-induced infection by Clostridium diﬃcile,320 which has
become a worldwide public health threat (Box 1). A contractile
nanotube engineered for speciﬁcity against a hypervirulent strain
of C. diﬃcile eﬃciently prevented infection of antibiotic-treated
mice, with no detectable eﬀects on the normal gut microbiota.320
In the context of infectious diseases, a unique beneﬁt of precision
antimicrobials is their potential for use not only as therapeutic
agents but also for prophylaxis, which is rarely indicated for
conventional antibiotics. A genetic approach with the potential
for genome modiﬁcation as well as precise ablation has recently
been developed using CRISPR-Cas technology in which RNA-
guided nucleases, delivered by transmissible plasmids or phage,
are engineered to alter speciﬁc DNA sequences to modify or to
kill a bacterial host.322
The above examples are based on engineering targeted
bactericidal molecules or structures using naturally occurring
components. The opportunity exists, however, to develop bio-
inspired nanomaterials with desirable properties and utility as
precision tools. Numerous types of nanoparticles have potent
antibacterial killing eﬃciency, including nitric-oxide-releasing
nanoparticles, nanoparticles containing chitosan, and metal-
containing Ag, Zn, Cu, Ti, Mg, or Au nanoparticles.323 The
ability to target these materials with phage-derived RBPs,
pheromones, or other speciﬁc binding ligands and to engineer
them to deploy only upon binding to bacterial cell surfaces would
provide a platform for an array of new approaches for developing
precision tools for microbiota management, as well as the treat-
ment and prevention of infectious diseases.
Observatories. Microbial observatories are instrumented
stations set in natural environments for long-term analyses of
microbial communities while at the same time observing hydro-
logical, geochemical, and other processes and interactions.324
The ﬁrst such observatories have been set in both marine and
continental environments across a range of geographical and geo-
chemical extremes. Integration of instruments to probe and
to culture microbes in situ has been used to increase the
microbiological experiments possible in these observatories.325
Figure 8. Cell penetration by a bactericidal contractile nanotube
(CTN). (A) CTN binds speciﬁcally to receptors on the outer
membrane (OM) of a bacterial cell using its six tail ﬁbers (two are
shown, top). Binding induces conformational changes in the outer
sheath (blue diagonals), injecting a hollow tube (black) across the
cell surface, inducing ion ﬂux, and depolarizing the inner membrane
(IM, bottom). (B) Electron micrographs of CTNs stained with
uranyl acetate. (C) Cryo-transmission electron microscopy-based
reconstruction of the trunk of a CTN in the extended state at 3.5 Å
resolution. (D) Segmented surface views of the extended CNT trunk
are shown with a cross section (lower right) showing the hollow
center of the tube. (E) Charged surface view of sheath−tube protein
interactions in the extended state (top left), with open-book view
(bottom right) highlighting charge complementarity. Sheath−tube
protein interactions are broken during contraction (top right).
(F) Precontraction (top) and postcontraction (bottom) sheath.
Cryo-EM density map (left) and ribbon diagrams of sheath subunits
(right) show rigid-body movement of subunits intertwined by
β-strand augmentation. Adapted with permission from ref 317.
Copyright 2015 Nature Publishing Group.
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Measurements of microbe catabolism and growth rates have
been performed in marine sediments as an example.326 Expan-
sion of both the enabling tools to these observatories and the
study of a greater range of environments such as topsoils
will provide critical data to elucidate trends and features arising
from microbiome habitats. Opportunities for nanoscience and
nanotechnology include networks of sensor arrays to monitor
chemical, physical, and biological environments, in addition to
the microbiome itself. Microbial observatories enable exper-
imentation on longer time scales and larger scales than typically
observed in laboratories and can operate with minimal disruption
from the microbiomes’ natural settings.
BIG AND/OR SMART DATA
Data Standardization, Quality Control, and Reposito-
ries. Another important task that needs to be addressed is the
creation of uniﬁed data standards and integrated data repositories
on microbiome-related imaging and sensing data that will
be utilized and accessed by various research communities and
organizations collecting, sharing, organizing, and analyzing
vast ranges of biomarkers, molecular signatures, gene proﬁles,
metabolites, etc. corresponding to diﬀerent microbiomes and
also as a function of both space and time. As discussed above,
these data might be collected using cost-eﬀective and massively
scalable interfaces and technological solutions based on, for
example, mobile phones or other consumer devices in addition
to mainstream standard laboratory-grade instruments, multi-
modal advanced imaging, and sensing interfaces. For this broad
aim, some important milestones that need be achieved include
(1) standardization of data/metadata formats as well as new
measurement hardware and peripherals (especially important for
ensuring quality measurements from citizen scientists); (2)
development of measures of and methods to assess data quality,
which need to include automated data cleaning and/or correction
techniques for elimination of false and/or contaminated data from
data repositories; and (3) addressing data ownership and ethics-
related issues, including but not limited to human−microbiome-
related data.
Image Labeling, Computer Vision, andCrowd-Sourcing/
Gaming Interfaces. In general, there is much detail and
subtlety associated with microscopic or nanoscopic multidimen-
sional image data, and therefore, accurate analysis and inter-
pretation of such images often become tedious and time-
consuming, even for highly trained professionals and experts.
This is probably one of the main reasons why machine-learning
and automated image-labeling strategies are still not widely
adopted for identiﬁcation and characterization of micro-organisms
through their microscopic/nanoscopic images. Even for bio-
medical diagnostic applications, such as identiﬁcation of a parasite
within a sample, machine learning is laggingmostly due to the lack
of large-scale gold-standard image libraries, whichmakes it diﬃcult
to leverage the power of some of the emerging Big Data analytics
tools that the industry (e.g., Google, Facebook, Amazon) has
been routinely utilizing for various image analysis and pattern
recognition tasks.
Crowd-sourcing of microbiome-related microscopic analysis
and image labeling/annotation is timely in several ways.327 With
rapid advances in mobile telecommunication and Internet
technologies such as mobile phones, tablet PCs, etc., we have
hundreds of millions of active users in the cloud that are all
connected to a global network. This current infrastructure and
the state of connectivity make it feasible to create a self-learning
data repository platform that leverages crowd-sourcing, gaming,
and communications theory concepts to conduct accurate and
sensitive analyses of microbiome image data in a distributed
fashion, even using nonexpert users and gamers.328 More
importantly, by coupling microbiome image data repositories
withmachine-learning and crowd-sourcing strategies, we can also
create a self-learning hybrid network, machine + human (i.e., both
professionals and citizen scientists) that gets much better in
automated identiﬁcation and classiﬁcation of microscopic images
of specimens. Through such large-scale data analysis, we can also
better identify statistically signiﬁcant parameters for individual
members of each microbial community, which is extremely
important to harness big data into “useful data” and “small data”,
also helping us to identify and to act on outliers.
All of these eﬀorts will need substantial cross-disciplinary
expertise to make decisions regarding the standards, regulations,
types of data that will be collected and analyzed, and how data
will be organized, processed, and accessed, so that the entire
resulting framework will ultimately be as useful as possible for
microbiome-related research at a global scale.
MODELING AND SIMULATIONS
Simulating Microbial Ecology. Sensors that can enable the
identiﬁcation and analysis of microbial community structure
and genotype distribution are essential to enabling us to view
the microbial world at the appropriate resolution to understand
the spatiotemporal dynamics we observe in soils, waters, and
even human bodies. However, these sensors will signiﬁcantly
increase the volume and immediacy of data acquisition, and while
this will improve statistical rigor and enable real-time validation
of predictions, the data stream needs to be handled appropriately
to provide input into predictive models at multiple scales.329
Well-developed and controlled feedback between observa-
tion and modeling has provided humanity with sophisticated
weather and climate system predictions and enabled ecological
predictions that provide information to support focused restora-
tion initiatives. Therefore, microbiome and metabolite forecasts,
analogous to current weather forecasts, are required for multiple
ecosystems, whereby new data are used to train and to reﬁne
existing models through a neural network that learns as data are
acquired.330 These microbial and metabolite forecasts must be
able to inform end users to facilitate the design and maintenance
of more resilient and productive ecosystems to support food
production, health promotion, pollution remediation, and global
environmental stability. Complementary bottom-up mechanistic
and top-down statistical models can capture the discrete or
continuous associations between environmental components
and microbial ecology with suﬃcient predictive power to model
changes and trends within an ecosystem. There are many dif-
ferent types of potential systems-scale models that enable us to
predict either the cellular processes that support emergent
ecosystem dynamics or the ecosystem processes that support
global emergent properties. Bottom-up mechanistic modeling
approaches include cellular systems-based prediction of
metabolic processes, including ﬂux-balance modeling of
individual cells or communities, cheminformatic approaches to
predict novel metabolic pathways, and agent-based models that
leverage multifactorial quantitative parametrization of ecosystem
properties (at both the cellular and community scale) to predict
interspecies interactions and outcomes within a given system.
Top-down statistical models include species distribution net-
work models that use relationships between external and bio-
logical parameters to predict outcomes or extrapolate observa-
tions, while dynamic Bayesian and convergent cross-mapping
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network models capture linear and nonlinear interactions that
support dynamic ecosystem properties. Examples of these
systems are given in Box 2.
Mechanistic models can be calculated based purely on
metagenomic and metabolomic data; these consist of genome-
scale metabolic models with course regulatory components for
eachmajor species identiﬁed in a system, which can be assembled
based on a combination of reference genome data and primary
reconstruction of annotated sequencing reads.339 Reference
genomes can provide data on course species behavior and
biology (e.g., redox preferences of species, general growth rates,
growth behavior) that can be used to facilitate simulation of
communities using a combination of steady-state community ﬂux
modeling to identify possible species interactions, and dynamic
ﬂux modeling to predict dynamic growth of all species over time
within a community.136 As one might imagine, dynamic models
require parameters, and generally, ﬂux models are signiﬁcantly
underdetermined. Put another way, there are many alterna-
tive schemes for interspecies interactions that are initially
equally feasible in these models. A means of identifying the
most plausible interactions and dynamic parameters to use in
constructing, testing, and validating dynamic community models
is required. This nexus is where the conceptual and quantitative
links with statistical models are applicable. Statistical models
operate at low systems resolution, statistically ﬁtting parameters
that represent course nonmechanistic interactions between
species, such that the statistical model can match observed
changes in species abundance in a microbiome over time. These
course parameters derived from the statistical models can be
translated into high-level constraints imposed on themechanistic
models. For example, a statistical model may determine that
species A and species B have a high probability for mutual
dependency based on analysis of their changing abundance
across a time series (using dynamic Bayesian or convergent cross-
mapping predictions; see Box 2). Longitudinal data are highly
important for the application of this technique, whereby the
temporal dynamics of the community are translated into a
constraint within a community metabolic model that ﬁlters
possible schemes for species interaction to only those schemes
that involve some form of mutual interaction between species A
and species B. Of course, these are not hard constraints because
the high-resolution mechanistic ﬂux modeling is based on
optimization approaches. Instead, the optimization algorithms
will favor predicted interactions between species based on the
probability for the interaction calculated by the statistical models.
So how is the mechanistic model adding information if the
statistical model has already predicted the species interaction?
Well, the statistical model predicts which species are likely to
be interacting, and the mechanistic model uses this information
to predict how these species are interacting such that the entire
community forms a single biochemically consistent system that
conforms to observed dynamics.
The outcome of these combined modeling eﬀorts based on
data acquired from continuous high spatiotemporal density
sensors monitoring microbiome dynamics will be the identi-
ﬁcation of the keystone taxonomic and metabolic components of
these systems. These keystone components, as in the keystone in
a bridge, support the whole system, helping to make it resilient,
robust, and stable. These models will identify the feedstocks that
form the base of any given microbial interaction network, as well
as the intermediate metabolites exchanged between organisms in
an interaction network. These interaction networks can form the
basis for subsequent dynamic models of microbiome evolution.
These models can predict the evolution of the microbiome
community structure over time, including interactions that may
involve exchange of a signal molecule or the removal of an
inhibitory compound (e.g., oxygen or fatty acid).
Stimulation and Response of Microbiomes. One long-
term vision for applied microbial research is that genetically
engineered microbes could be released into the wild, perform a
useful task, and then disappear without environmental disruption
or genetic contamination of the ecosystem. Applications could
include probiotic microbes used as therapeutics and prophy-
lactics for the health of the gut, skin, and lungs in humans
and livestock; photosynthetic microbes living in open ponds
that produce commodities; carbon-ﬁxing microbes that capture
CO2 from coal-burning power plants; bacteria that compete with
fungal parasites that endanger food crops (which is becoming
more urgent due to global warming and crop monoculture);
microbes engineered to metabolize insecticides and other toxins
in cleanup sites; microbes that sense chemicals that may represent
security threats, such as explosives or neurotoxins; and so on.
Synthetic biologists have conceptualized and developed a large
number of such useful microbes, but deployment is always
stymied by the same problem. If we release such organisms into
the environment, what will happen after they carry out their
function? Will they evolve into pests and disrupt an ecosystem?
Will they exchange genetic information with other microbes to
create hybrids in which genetically engineered modules become
established in the wild?
Unless these worries are addressed, synthetic microbiologists
may continue to create useful microbes, but these will remain
in the realm of “toy systems”. An important area of research will
be in containment systems for engineered microbes. These
“systems” would not be physicalrather, we need biologically
based containment. As an illustration, one promising approach is
the development of “recoded” organisms in which the genetic
codethe correlation between bases in DNA and amino acids
is completely rewritten for an engineered microbe (Figure 9). In
this way, if DNA is transferred in or out of the organism, the
transferred DNA cannot be read and will provide no selective
advantage. This type of technology is broadly enabling for
commercial and defense applications, but it is not currently
funded and needs support in order to reap the beneﬁts of syn-
thetic biology outside the laboratory.
One example of the potential advantages of manipulating
microbiomes is in treating obesity, which has become a global
epidemic. Studies in both mice and humans have implicated gut
microbiomes in the ability to harvest energy from food.340 Selec-
tively replacing gut microbiomes in mice indicated the divergent
paths that individuals could take in their synergy with and
dependence on their microbiomes.
ETHICS
Understanding how integrated microbial systems work within
and with the environment, whether that environment is a living
organismal “host”, a biofuel reactor, or an agricultural soil, is a
grand scientiﬁc goal. However, a number of ethical issues must be
considered in basic microbiomes research and in association with
manipulation of environmental and human microbiomes. For
example, open data sharing has been proposed for the micro-
biome initiative, including for human microbiome data, yet
human gut microbiomes can be traced to particular patients341
and may indicate health status and age, among other private
attributes.342 The public will reap the beneﬁt of insights gleaned
from microbiomes research when information access is broad,
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but individuals will shoulder the risk to their privacy from misuse
of information. Though human microbiomes are more ﬂuid than
whole human genomes, the fact that under some circumstances
microbiomes can be tied to particular individuals suggests that
similar ethical considerations343 should be tackled.
In documents focused on whole-genome sequencing in
humans and on synthetic biology, the Presidential Commission
on Bioethical Issues emphasizes ﬁve ethical principles to guide
research practices:344,345 public beneﬁcence, responsible stew-
ardship, intellectual freedom and responsibility, democratic
deliberation, and justice and fairness. These same basic principles
can inform human and environmental microbiomes research.
“Public beneﬁcence” aims to maximize beneﬁt and minimize
harm to the public and entails continuous re-evaluation of
promise and risk from safety, security, environmental, economic,
and social perspectives.346 “Responsible stewardship” requires
that the global community consider long-term and widespread
implications of actions for our shared environment, for the
currently disenfranchised, and for future generations. “Justice
and fairness” emerge from responsible stewardshipbeneﬁts of
new knowledge should accrue to all of society. “Intellectual
freedom” to pursue emerging technologies, though they are by
nature continuously changing, must be delicately balanced with
the development of a regulatory structure to ensure responsible
action.347 “Democratic deliberation” should be at the heart of
community decision-making, with the goal of societal beneﬁt
outweighing individual interests, and with input from philoso-
phy, social sciences, and the general public to maintain public
legitimacy.346
Beyond the ethical issues associated with study and
manipulation of human microbiomes, manipulation of organ-
ismal and environmental microbiomes to improve food and fuel
supplies, or potentially even to counter global climate change,
also requires scientiﬁc, ethical, political, and legal input. Microbes
have tremendous promise as partners in Earth stewardship; they
have shaped and maintained Earth’s life support systems for
billions of years. The ﬁrst priority of scientists must be to obtain
understanding deep enough to consider both the promise and
the potential perils (unintended consequences) of attempts
to harness microbial activities operating in ecosystems or at
planetary scales. Even within organisms, manipulation of a single
gene can lead to surprising results.346 The complexity of micro-
biomes comprising multiple organisms interacting with their
environment is far higher; the potential for unintended
consequences of microbiome manipulation is thus a very real
risk, particularly in the imperfectly understood natural Earth
systems on which all humanity depends.348 A highly visible
example of proposed manipulation of an environmental micro-
biome is the decades-old, controversial (bio)geoengineering pro-
posal to fertilize the ocean, in order to stimulate phytoplankton
growth, bury resulting organic carbon deep in the ocean after it
sinks from upper ocean layers, and thus mitigate increasing
concentrations of atmospheric carbon dioxide.349 The London
Convention/London Protocol formed an international gover-
nance and assessment framework for research testing this geo-
engineering technique.348 Similar frameworks will be essential
before considering any large-scale manipulation of environ-
mental microbiomes, as concerns will emerge over responsibility,
liability for unintended ecological impacts, open and cooperative
research, evaluation, assessment, and public consent.348,350
PROSPECTS
There are tremendous opportunities for nanoscience and
nanotechnology to contribute to understanding the microbiome.
The ability to image, to sense, and to stimulate at the scale of
function will be critical in measuring and ultimately under-
standing the microbiome. Hybrid synthetic/biological nano-
structures will yield precise tools to manipulate the microbiome
and also to address key challenges in medicine. Such advances
will enable us to reshape microbiomes in systems ranging from
the gut to the global rhizosphere. New ways of dealing with the
information obtained from what will necessarily involve multiple
measurement modalities will be required. Such data acquisition
and data science opportunities can be used to broaden the
community of those working on the microbiome. We anticipate
that the combinations of nanotechnology with synthetic biology
and other ﬁelds will generate fertile new science and applications,
in health, agriculture, climate science, energy, and other areas.
We hope and anticipate that, like the BRAIN Initiative,168 the
microbiome initiative will leverage the worldwide investments
in science, technology, and people in nanoscience and nano-
technology1,3,351,352 to bear on exploring and understanding the
microbiome and will generate a new world of scientiﬁc questions
and opportunities.
Figure 9. Synthetic biology can be used to modify organisms that can interact with and thereby drive changes in microbiomes.
ACS Nano Nano Focus
DOI: 10.1021/acsnano.5b07826
ACS Nano 2016, 10, 6−37
27
AUTHOR INFORMATION
Corresponding Authors
*E-mail: robknight@ucsd.edu.
*E-mail: jfmiller@ucla.edu.
*E-mail: psw@cnsi.ucla.edu.
Notes
The authors declare the following competing ﬁnancial
interest(s): P.C.B. is an equity holder in GALT, Inc. and 10X
Genomics, and is a co-inventor of technologies for micro-
analytical systems that may be commercialized. G.M.C. is
consultant and shareholder of Seres Therapeutics and has other
broader involvements (listed at http://arep.med.harvard.edu/
gmc/tech.html). S.E.F. holds patents for imaging tools, some of
which are deployed as imaging diagnostics (at Varocto, Inc.) or
are licensed to Zeiss. J.F.M. is a cofounder, equity holder, and
chair of the scientiﬁc advisory board of AvidBiotics Inc., a
biotherapeutics company in San Francisco, California. R.K. is co-
founder and CEO of Biota Technology, Inc., which uses data
science and microbial DNA for oilﬁeld applications. A.O. is the
co-founder of a company that commercializes imaging and
sensing technologies for medical diagnostics applications. S.R.Q.
is a consultant and shareholder of Fluidigm and Karius. G.v.d.E. is
co-inventor of ﬂow cytometers and related instruments that have
been licensed and for which he receives royalties related to cell-
sorting technologies as tools for genome/biome analyses.
ACKNOWLEDGMENTS
We gratefully acknowledge the Kavli Foundation for support and
encouragement of this initiative and the discussions that led up to
it. This research was supported by the Oﬃce of Naval Research
Grant #N000141410051 (P.S.W., G.C.L.W., and T.Y.), the
Genomic Science Program of the U.S. DOE-OBER, and is a
contribution of the PNNL Foundational Scientiﬁc Focus Area
(J.K.J. and A.W.) and the Panomics project (A.W.) at the Paciﬁc
Northwest National Laboratory, a multiprogram national
laboratory operated by Battelle for the DOE under Contract
DE-AC06-76RL01830. The authors acknowledge helpful
discussions with Profs. Paul Alivisatos, Anne Andrews, Xiangfeng
Duan, Lee Hood, Yu Huang, Andrea Kasko, Ken Nealson, and
Sunney Xie, as well as with many of our other colleagues.
We thankMs. Andrea Selby for the table of contents artwork, Dr.
Jessica Polka for help with graphics, andMs. Holly Bunje for help
in preparing the manuscript.
REFERENCES
(1) Alivisatos, A. P.; Blaser, M. J.; Brodie, E. L.; Chun, M.; Dangl, J. L.;
Donohue, T. J.; Gilbert, J. A.; Green, J. L.; Jansson, J. K.; Knight, R.;
Maxon,M. E.;McFall-Ngai, M. J.; Miller, J. F.; Pollard, K. S.; Ruby, E. G.;
Taha, S. S. A Unified Initiative to Harness the Earth’s Microbiomes.
Science 2015, 350, 507−508.
(2) Miller, J. F. et al. Towards a Predictive Understanding of Earth’s
Microbiomes to Address 21st Century Challenges. Proc. Natl. Acad. Sci.
U. S. A. Manuscript in preparation.
(3) Parak, W. J.; Nel, A. E.; Weiss, P. S. Grand Challenges for
Nanoscience and Nanotechnology. ACS Nano 2015, 9, 6637−6640.
(4) Savage, D. C. Microbial Ecology of the Gastrointestinal Tract.
Annu. Rev. Microbiol. 1977, 31, 107−133.
(5) Costello, E. K.; Lauber, C. L.; Hamady, M.; Fierer, N.; Gordon, J. I.;
Knight, R. Bacterial Community Variation in Human Body Habitats
Across Space and Time. Science 2009, 326, 1694−1697.
(6) The Human Microbiome Project Consortium. The Human
Microbiome Project Consortium. Structure, Function, and Diversity of
the Healthy Human Microbiome. Nature 2012, 486, 207−214.
(7) Ley, R. E.; Lozupone, C. A.; Hamady, M.; Knight, R.; Gordon, J. I.
Worlds withinWorlds: Evolution of the Vertebrate GutMicrobiota.Nat.
Rev. Microbiol. 2008, 6, 776−788.
(8) Worden, A. Z.; Follows, M. J.; Giovannoni, S. J.; Wilken, S.;
Zimmerman, A. E.; Keeling, P. J. Rethinking the Marine Carbon Cycle:
Factoring in the Multifarious Lifestyles of Microbes. Science 2015, 347,
1257594.
(9) Oswald, R.; Behrendt, T.; Ermel, M.; Wu, D.; Su, H.; Cheng, Y.;
Breuninger, C.; Moravek, A.; Mougin, E.; Delon, C.; Loubet, B.;
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Dependence Gives Rise to Collective Oscillations within Biofilms.
Nature 2015, 523, 550−554.
(172) Moree, W. J.; Phelan, V. V.; Wu, C. H.; Bandeira, N.; Cornett, D.
S.; Duggan, B. M.; Dorrestein, P. C. Interkingdom Metabolic
Transformations Captured by Microbial Imaging Mass Spectrometry.
Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 13811−13816.
(173) Park, S.; Wolanin, P. M.; Yuzbashyan, E. A.; Silberzan, P.; Stock,
J. B.; Austin, R. H. Motion To Form a Quorum. Science 2003, 301, 188−
188.
(174) Smith, R. K.; Lewis, P. A.; Weiss, P. S. Patterning Self-Assembled
Monolayers. Prog. Surf. Sci. 2004, 75, 1−68.
(175) Love, J. C.; Estroff, L. A.; Kriebel, J. K.; Nuzzo, R. G.; Whitesides,
G. M. Self-Assembled Monolayers of Thiolates on Metals as a Form of
Nanotechnology. Chem. Rev. 2005, 105, 1103−1169.
(176) Saavedra, H. M.; Mullen, T. J.; Zhang, P. P.; Dewey, D. C.;
Claridge, S. A.;Weiss, P. S. Hybrid Approaches in Nanolithography. Rep.
Prog. Phys. 2010, 73, 036501.
(177) Qian, X.; Metallo, S. J.; Choi, I. S.; Wu, H.; Liang, M. N.;
Whitesides, G. M. Arrays of Self-Assembled Monolayers for Studying
Inhibition of Bacterial Adhesion. Anal. Chem. 2002, 74, 1805−1810.
(178) Weibel, D. B.; Lee, A.; Mayer, M.; Brady, S. F.; Bruzewicz, D.;
Yang, J.; DiLuzio, W. R.; Clardy, J.; Whitesides, G. M. Bacterial Printing
Press that Regenerates Its Ink: Contact-Printing Bacteria Using
Hydrogel Stamps. Langmuir 2005, 21, 6436−6442.
(179) Barth, K. A.; Coullerez, G.; Nilsson, L. M.; Castelli, R.;
Seeberger, P. H.; Vogel, V.; Textor, M. An Engineered Mannoside
Presenting Platform: Escherichia coli Adhesion under Static and
Dynamic Conditions. Adv. Funct. Mater. 2008, 18, 1459−1469.
(180) Costello, C. M.; Kreft, J.; Thomas, C. M.; Hammes, D. M.; Bao,
P.; Evans, S. D.; Mendes, P. M. Exploiting Additive and Subtractive
Patterning for Spatially Controlled and Robust Bacterial Co-Cultures.
Soft Matter 2012, 8, 9147−9155.
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